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ABSTRACT 
The Vancouver Island Marmot (Marmota vancouverensis) is an endangered 
rodent endemic to the mountains of Vancouver Island, British Columbia, Canada. 
Following population declines in the 1980s and 1990s, an intensive captive breeding 
and reintroduction program was initiated involving three Canadian zoos and a 
purpose-built, subalpine facility on Vancouver Island. 
From 1997 to 2017, 660 marmots were associated with the captive program, 
including 63 wild-born individuals captured for breeding and 597 marmots born 
and weaned in captivity. Reintroductions began in 2003 and by 2017 a total of 501 
marmots had been released. Although this significantly increased the wild 
population from its low point in 2003, conservation of the Vancouver Island Marmot 
(VIM) continues to involve intensive ex situ management, reintroductions, and 
translocations.  
Health and disease surveillence is fundamental to the success of conservation 
programs like the marmot recovery project. This thesis builds upon our 
understanding of VIM health by describing and evaluating select health parameters, 
to determine baseline characteristics for VIM under its different treatments (wild, 
captive and captive-release) and to identify potential risk factors that may influence 
the health of the marmot’s population and its capacity to achieve recovery 
objectives. The analysis involved data that was collected between 1992 and 2016, and 
included 1,106 VIM blood profiles, 3,174 physical examinations, 140 post mortem 
examinations and 533 field mortality records.  
VIM hematology and serum biochemistry reference ranges were calculated as 
a baseline metric and were qualitatively comparable to published values for other 
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rodent species. Leukogram and protein values were found to have potential utility 
as a quantitative measure for comparing VIM management groups. 
There were significant differences in the clinical and pathological data 
collected from captive and free-ranging (captive-release and wild) marmots. 
Captives could be monitored with greater intensity and to an older age, due to 
increased longevity. A host of clinical and pathological disorders were described in 
captive marmots, including age-related, management-related, and congenital 
problems. There was a paucity of health conditions identified in free-ranging VIM 
and this could be due to a fundamental lack of disease, or limited opportunities to 
conduct post mortem examinations or evaluate compromised individuals in the 
field.  
The analysis did not identify any specific infectious agents that represented a 
generalized population threat to VIM. Cardiomyopathy and neoplasia, which 
occurred in older individuals, were the most consequential health complications for 
captive marmots. Implantation of abdominal radio-transmitters was not found to 
impact marmot health and was important for identifying mortalities in the field. The 
first wild hibernation represented a time of significant mortality for VIM released 
from captivity. However, reintroduced marmots that survived their first year in the 
wild were comparable to their wild-born counterparts with respect to hibernation 
success and clinical presentation. Predators continued to represent a major cause of 
mortality for free-ranging marmots. In the absence of other identified health threats, 
predation and reduced hibernation success of captive-release marmots appear to be 
significant factors limiting the health and potential recovery of the in situ 
population.   
Keywords: marmot, endangered, recovery, health, disease, surveillance 
iv 
 
 
TABLE OF CONTENTS 
ABSTRACT ................................................................................................................................ ii 
TABLE OF CONTENTS  ............................................................................................................. iv 
ACKNOWLEDGEMENTS  ........................................................................................................ vii 
DEDICATION ........................................................................................................................... ix 
LIST OF FIGURES ...................................................................................................................... x 
LIST OF TABLES ...................................................................................................................... xii 
CHAPTER 1: THESIS INTRODUCTION ......................................................................................1  
Health Risks in Threatened Species .........................................................................2 
Individual Health ........................................................................................................4 
Population Health .......................................................................................................4 
The Vancouver Island Marmot .................................................................................6 
Marmot Recovery and Current Status ...................................................................10 
Thesis Structure .........................................................................................................14 
Literature Cited .........................................................................................................15 
CHAPTER 2: HEMATOLOGICAL AND SERUM BIOCHEMICAL PARAMETERS IN THE 
VANCOUVER ISLAND MARMOT: REFERENCE RANGES AND A COMPARISON OF 
VALUES BETWEEN MANAGEMENT GROUPS 
Introduction ...............................................................................................................20 
Materials and Methods.............................................................................................22 
Results .........................................................................................................................29 
Discussion ..................................................................................................................56 
Literature Cited .........................................................................................................60 
 
v 
 
 
CHAPTER 3: SURVEILLANCE OF VANCOUVER ISLAND MARMOT HEALTH USING 
CLINICAL AND POST MORTEM EXAMINATIONS, AND FIELD MORTALITY 
DETERMINATION  
Introduction ...............................................................................................................64 
Materials and Methods.............................................................................................67 
Results .........................................................................................................................78 
Discussion ..................................................................................................................98 
Literature Cited .......................................................................................................104 
CHAPTER 4: CONCLUSION ...................................................................................................107 
Literature Cited .......................................................................................................116 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
 
LIST OF APPENDICES 
 
APPENDIX A. Vancouver Island Marmot captive population numbers, 1997 to 2018 ..... 
 ....................................................................................................................................118 
 
APPENDIX B.  Descriptive statistics for hematological variables from clinically normal 
or healthy Vancouver Island Marmots before & after removal of outliers ....119 
 
APPENDIX C.  Descriptive statistics for serological variables from clinically normal or 
healthy Vancouver Island Marmots before & after removal of outliers .........121 
 
APPENDIX D. Characteristics of implantable abdominal transmitters used in 
Vancouver Island Marmots 1992 to 2018 .............................................................124 
 
APPENDIX E. Summary of Vancouver Island Marmot implant surgeries, 1992 to 2018 
 ....................................................................................................................................126 
 
APPENDIX F. Trapping, handling, anesthesia & implant surgery techniques in 
Vancouver Island Marmots ...................................................................................127 
 
APPENDIX G. Summary of morbidity & mortality in captive & free-ranging 
Vancouver Island Marmots 1992 to 2016 .............................................................136 
 
APPENDIX H. Summary of annual mortalities in free-ranging Vancouver Island 
Marmots 1992 to 2016 .............................................................................................138 
 
APPENDIX I. A comparison of common body condition indices in wild & captive 
male Vancouver Island Marmots ..........................................................................139 
 
 
 
 
  
vii 
 
 
ACKNOWLEDGEMENTS 
Dave Fraser, the Endangered Species Specialist for British Columbia’s 
Ministry of Environment (and a former member of the Vancouver Island Marmot 
Recovery Team), once told me that the most successful conservation efforts were the 
ones driven by individuals who are passionate about the cause. Over many years, 
marmot recovery, and my own humble thesis, have benefited greatly from the hard 
work, expertise, and passion of many people.  
This includes the animal care, curatorial, and veterinary staffs at the Toronto 
Zoo and the Calgary Zoo, and Gordon Blankstein and the workforce at the 
Mountain View Conservation and Breeding Society. Collette Howell, Rick Wenman 
and Debbie Rempel were instrumental in developing the initial protocols for 
marmot husbandry and breeding. Dr. Doug Whiteside, Dr. Sandie Black, Dr. 
Graham Crawshaw, Dr. Chris Dutton and many other veterinarians, have made 
important contributions to marmot health. The staff at the Tony Barrett Mount 
Washington Marmot Recovery Centre, particularly Louise Dykslag and Alana 
Buchanan, contributed many years of diligent animal care.  
A number of pathologists at the University of Guelph, the Calgary Zoo and 
the Animal Health Centre (AHC) in Abbotsford conducted marmot post mortems. 
Dr. Stephen Raverty (AHC) deserves special recognition for his thoroughness, 
expertise and the number of marmot cases he examined. He went out of his way on 
many occasions to provide us with his insights and support.  
The Vancouver Island Marmot Recovery Team and the Captive Management 
Group grappled with difficult decisions and dealt with contentious issues in a 
consistently thoughtful and respectful manner. Tremendous leadership was shown 
by the Recovery Team Chairs - Doug Janz, Don Doyle and Sean Pendergast (current) 
viii 
 
 
- and by the Executive Directors of the Marmot Recovery Foundation (MRF), the late 
Tony Barrett, the late Robert Huber, Viki Jackson and Adam Taylor (current). The 
late Jim Walker, former Chair of the MRF Board, and many MRF board members, 
were vital advocates for the marmots. An army of field personnel endured extreme 
temperatures, biting insects, lumpy ground, challenging terrain, predators and 
many long days and nights. This included Cheyney Jackson (current MRF Field Co-
ordinator), Mike Lester, Jerry MacDermott, Sean Pendergast, Crystal Reid, Chris 
White and many, many others.   
Dr.  Andrew Bryant was important to VIM and the project in many ways, and 
along with Tony Barrett and Stan Coleman, was instrumental in getting the MRF off 
the ground. Dr. Ken Langelier developed many of the original techniques used for 
surgically implanting radio-transmitters. Robin Campbell and the North Island 
Wildlife Recovery Association provided support in a multitude of ways.  John 
Carnio was instrumental in starting the captive breeding program at the Toronto 
Zoo and has acted as the VIM Studbook Keeper since its inception. His sage wisdom 
has been valued for many years. His successor at the Toronto Zoo, Maria Franke, has 
been a strong voice for the marmots. Dr. Helen Schwantje has been an instrumental 
and multi-faceted contributor and promoter of marmot health.  
Dr. David Hill (a member of my thesis committee) spent valuable time 
helping me learn the basics of statistics, and Dr. Todd Shury was a welcome 
addition as my external examiner. I would like to thank my supervisors, Dr. Craig 
Stephen and Dr. Karl Larsen, for their friendship, guidance and patience. It was very 
much appreciated.  
And a thanks to the VIM themselves, who live their lives as marmots, and do 
not stress about being critically endangered. A lesson to us all.    
ix 
 
 
DEDICATION 
This thesis is dedicated to Marnie, Steven, Greg, Laura, Vern and Margaret. You 
didn’t always understand my passion for wildlife, but you accepted and supported 
it nevertheless. 
 
 
Haida (right) was born in 2002 at the Mountain View Conservation and Breeding Society in 
Langley, British Columbia and became the first captive-release female to breed in the wild. 
Her descendants continue to survive at the Haley Lake Ecological Reserve on Vancouver 
Island. Photo: Oli Gardner 
 
 
 
People often ask me ‘What are marmots good for?’, I ask them “What are you good 
for?” 
 
Dr. Kenneth B. Armitage 
x 
 
 
LIST OF FIGURES 
 
Figure 1.1. Historical distribution of the Vancouver Island Marmot ..............................8 
 
Figure 1.2.  Size of the Vancouver Island Marmot population from 1997 to 2017 ......13 
 
Figure 2.1. Schematic diagram illustrating the relationships and sample size of the 
Vancouver Island Marmot blood sampling categories .......................................26  
 
Figure 2.2. Annual distribution of 1,106 blood samples collected from Vancouver 
Island Marmots 1992 to 2015 ...................................................................................31 
 
Figure 2.3. Monthly distribution of 1,106 blood samples collected from captive and 
free-ranging Vancouver Island Marmots ..............................................................31  
 
Figure 2.4. Sex and age distribution of 1,106 blood samples collected from captive 
and free-ranging Vancouver Island Marmots ......................................................32 
 
Figure 2.5. Comparison of age distribution of 1,106 blood samples collected from 
captive and free-ranging Vancouver Island Marmots .........................................32  
 
Figure 2.6. Changes in total white blood cells and total protein from April to October 
for clinically normal Vancouver Island Marmots ................................................42 
 
Figure 2.7. Boxplot comparisons of red blood cells and hemoglobin between June 
and October for clinically normal Vancouver Island Marmots .........................43   
  
Figure 2.8. Change in red blood cells and hemoglobin for clinically normal 
Vancouver Island Marmots according to age .......................................................44 
 
Figure 2.9. Change in glucose and amylase for clinically normal Vancouver Island 
Marmots according to age ......................................................................................................... 45   
 
Figure 2.10. Boxplots comparing male and female values for hematocrit and amylase 
in Vancouver Island Marmots .................................................................................46  
 
 
xi 
 
 
Figure 3.1. Age comparison of physical examinations conducted on wild and captive 
Vancouver Island Marmots .....................................................................................81  
 
Figure 3.2. Sex-age distribution of 109 mortalities in captive, weaned Vancouver 
Island Marmots 1997 to 2016 ...................................................................................88 
 
Figure 3.3. Sex-age distribution of 518 mortalities in free-ranging Vancouver Island 
Marmots 1992 to 2016 ...............................................................................................88 
 
Figure 3.4. Yearly predation mortalities of free-ranging Vancouver Island Marmots 
1992 to 2016 ................................................................................................................96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
xii 
 
 
LIST OF TABLES 
 
Table 2.1. Reference intervals for 16 hematological parameters from clinically 
healthy Vancouver Island Marmots .......................................................................33 
 
Table 2.2. Reference intervals for 30 serum biochemistry parameters from clinically 
healthy Vancouver Island Marmots .......................................................................34 
 
Table 2.3. Vancouver Island Marmot hematological and serological mean values 
compared to published means for the Woodchuck (Marmota monax) and 
normal values published for Mice (Mus musculus), Rats (Rattus norvegicus), 
Gerbils (Meriones unguiculatus), and Guinea Pigs (Cavia porcellus) ....................36 
 
Table 2.4. Hematology values comparing healthy captive (un-implanted), wild and 
captive-release Vancouver Island Marmots ..........................................................47 
 
Table 2.5. Serum biochemistry values comparing healthy, captive (un-implanted), 
wild and captive-release Vancouver Island marmots .........................................48 
 
Table 2.6. Hematology values comparing (i) clinically normal, non-implanted, (ii) 
clinically normal, implanted, and (iii) clinically abnormal Vancouver Island 
Marmots .....................................................................................................................50 
 
Table 2.7. Serum biochemistry values comparing clinically normal non-implanted 
and implanted and clinically abnormal Vancouver Island Marmots ...............51 
 
Table 2.8. Summary of statistical and clinical significance in hematology parameters 
between specific treatments or groups of Vancouver Island Marmots ............53 
 
Table 2.9. Summary of statistical and clinical significance in serology parameters 
between specific treatments or groups of Vancouver Island Marmots ............54 
 
Table 3.1. Circumstances of 3,174 physical examinations conducted on captive and 
free-ranging Vancouver Island Marmots ..............................................................80 
 
Table 3.2. Clinical conditions initially identified from 3,174 Vancouver Island 
Marmot physical examinations ...............................................................................85 
xiii 
 
 
 
Table 3.3. Categories of mortality observed in 109 captive Vancouver Island 
Marmots 1997 to 2016 ...............................................................................................87 
 
Table 3.4. Anatomical description of neoplasia in 26 captive Vancouver Island 
Marmots 1997 to 2016 ...............................................................................................89 
 
Table 3.5. Causes of mortality for wild, translocated, captive-release and pre-
conditioned Vancouver Island Marmots ...............................................................94 
 
Table 3.6. Predator mortality for wild, translocated, captive-release and pre-
conditioned Vancouver Island Marmots ...............................................................95 
 
Table 3.7. Post mortem diagnosis in 8 (7 telemetered, 1 non-telemetered) wild 
Vancouver Island Marmots 1992 – 2016 ................................................................97 
 
Table 3.8 Post mortem diagnosis in 23 captive-release Vancouver Island Marmots 
2003 – 2016 ..................................................................................................................97 
 
 
 
 
 
 
1 
 
 
CHAPTER 1 
THESIS INTRODUCTION 
 
To prevent extinction and facilitate recovery, many conservation programs 
have undertaken intensive management of endangered species. In the case of the 
critically endangered Vancouver Island Marmot (Marmota vancouverensis) this has 
involved captive breeding and conservation translocations, the latter defined as the 
deliberate movement of individuals from one location, either captive or wild, to free 
release in another location, to restore extirpated populations or to support existing 
small populations (Convention on Biological Diversity, 2013; Ewan et al. 2012; 
Williams & Hoffman, 2009; Teixeira, et al. 2007; Rout et al., 2007; IUCN, 2002; Fischer 
& Lindenmayer, 2000; Ebenhard, 1995). Dwindling numbers and artificial 
manipulation, including animal movements and ex situ management, have the 
potential to negatively impact the health of a threatened species (Daszak, et al. 2001; 
Snyder, et al. 1996). Although comprehensive tracking of health and health effects in 
imperiled wildlife populations is essential for their successful long-term 
maintenance and recovery, and for the timely recognition and mitigation of 
potential threats, effective health monitoring and its implications represents a 
significant challenge for many conservation programs (Delahay et al. 2009).  
The objective of this thesis is to build upon our current understanding of 
Vancouver Island Marmot (VIM) health by describing and evaluating select health 
parameters, to determine what is expected for this species under different 
treatments (wild, captive and captive-release) and to identify possible risk factors 
associated with small population size and conservation management that may be 
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influencing the health of the marmot’s population and its relative capacity to achieve 
defined recovery objectives. 
 
HEALTH RISKS IN THREATENED SPECIES 
Declines in population size can result in a loss of genetic diversity that may 
compromise an endangered species’ capacity to cope with current conditions or 
adapt to future change (Jamieson, 2010). Decreased heterozygosity can have 
multiple consequences including a reduction in rigour, growth, fecundity, survival, 
and immunocompetence, and it may also lead to the accumulation and expression of 
deleterious alleles (Ewan et al. 2012; Williams and Hoffman, 2009). Captivity can 
significantly alter animals (Darwin, 1859) and artificial conditions may promote the 
occurrence of heritable or acquired traits that reduce the fitness of individuals being 
returned to the wild (Kreger et al. 2005). Many translocation programs using captive-
bred animals have been less successful than those ultilizing wild-born animals 
(Robert, 2009; Teixeira et al. 2007, Jule, Leavor, & Lea, 2008; Fischer & Lindenmayer, 
2000). The post-release success of captive animals may be limited by physical, 
physiological and behavorial deficiencies, including inadequate physical 
conditioning, underdeveloped locomotor abilities, morphological changes, alteration 
of reproductive and metabollic cycles, increased stress, inadequate or inappropriate 
anti-predator or threat responses, overt boldness or aggression, increased docility, 
alterred sociocognitive abilities, and an inability to recognize or procure appropriate 
foods (Bonato et al. 2013; Teixeira et al. 2007; Hare, et al., 2005; McPhee, 2003; 
Concannon et al. 1997). Rapid genetic changes associated with domestication may 
occur within a single generation in certain taxa (De Mestral & Herbinger, 2013) and 
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some abberant characteristics may become more pronounced or more variable 
following multiple generations in captivity (McPhee, 2003).  
Captive confinement also can result in the artificial intensification of endemic 
parasites, or alternatively it may result in a reduction of acquired resistence due to 
the disruption of natural relationships that are normally maintained between a host 
and its commensal pathogens and parasites (Mathews et al. 2005). Most zoological 
institutions maintain geographically-varied collections of animals from a diversity of 
sources, each with their own spectrum of infectious agents (Snyder, et al. 1996). In 
addition, captive facilities may inadvertently harbour pest species, which provide an 
additional source for the introduction of exotic pathogens. Even with the safeguard 
of good biosecurity, there is always the potential risk that an ex situ recovery 
population maintained within a zoo will be exposed to a novel pathogen. This 
potential risk cannot be fully quantified because it is not realistically possible to 
determine the full spectrum of suseptibilty that an endangered species has to novel 
infectious agents. 
Whenever animals are translocated from one environment to another (be it 
wild to captive, captive to captive, captive to wild or wild to wild) there is a risk to 
the health of the individuals being moved and a risk to the health of extant 
individuals or populations (Leighton, 2002; Woodford, 1993). Translocated animals 
may serve as vectors for the introduction of novel pathogens to naïve recipient 
populations, or alternatively, they may be naïve to the transmissible agents that exist 
within the extant conspecific or sympatric populations at their release site.  
 
 
 
4 
 
 
INDIVIDUAL HEALTH 
To survive and propagate, organisms must co-ordinate complex assemblages 
of functional and metabolic characteristics that allow for the maintenance of intrinsic 
equilibrium, or homeostasis. To be effective, this physiological balance must be 
maintained within the typical range of ambient conditions to which a species has 
become adapted, and to some extent, it must also be preserved in response to 
atypical perturbations (Ryser-Degiorgis, 2013). Within a species, there is individual 
variability in the capacity to cope or self-manage. Those individuals that are less 
competent at regulating biological integrity or those that are less able to maintain 
function during times of challenge or stress, have diminished resilience and are 
potentially inferior with respect to growth, reproduction, and survival (Darwin, 
1859). An individual’s capacity to maintain homeostasis, well-being, and normal life 
functions, can be equated to its comparative state of health. A reduced ability to 
support homeostasis can result in biological impairment and this can be associated 
with imbalance or disease (Ryser-Degiorgis, 2013). If health is used in the context of 
a continuum or relative state (i.e. an individual’s ability to sustain biological 
processes and its productivity at specific points in life, or cumulatively over a 
lifetime, compared to conspecifics) it does not merely represent the absence of 
observable dysfunction or disease (Gunnarsson, 2006).  
 
POPULATION HEALTH 
Although health in individuals can be quantified by measurable 
characteristics or outcomes relative to those of conspecifics or even individuals of 
other species, it is much more difficult to define and evaluate the health of 
populations, species, and the intricate ecosystems of which they are a part (Deem et 
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al. 2008). Many wildlife studies evaluating health have emphasized the description 
of dysfunction, pathogens, and mortality in populations (Ryser-Degiorgis, 2013). 
Although the occurrence of infectious and non-infectious disease and the factors that 
predispose populations to disease are important to comprehensive monitoring and 
conservation, this type of data represents only one component in the multifaceted 
context of population health. Health surveillance also can involve the evaluation of 
many other parameters and condition indices, including growth, physical 
characteristics and body condition, fecundity, longevity, survival rates, recruitment 
rates, commensal microflora, behavior, demographics, physiological and 
immunological measures, and genetic diversity (Robert & Schwanz, 2013; Sackett et 
al. 2013;  Brashares et al. 2010; Mellish et al. 2010; Villers et al. 2008; Mathews et al. 
2006; Stevenson & Woods, Jr., 2006; Ostermann et a., 2001). A workable health 
construct for a species can be based on two basic components - a normative 
component and a descriptive component (Hanisch, et al. 2012). 
The normative component of population health seeks to address what should 
be, by identifying an ideal standard or holistic condition of population well-being, 
and by determining what is required to restore or maintain that condition (Hanisch, 
et al. 2012). The ideal, healthy wildlife population could be one that is self–
sustaining, and able to survive within its natural habitat, while maintaining its 
intricate ecological relationships without the need for artificial support or 
intervention. Such a population should have the capacity to persist for a prolonged, 
but indeterminate period and avoid premature extinction. It must have the intrinsic 
ability to cope with existing and future stressors, and demonstrate resiliency and 
sustainability. Threatened populations, by their very definition, lack the capacity to 
autonomously achieve these normative ideals of integrity and health. From a 
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conservation and management perspective, the comparative state of fitness or health 
of a threatened or recovering wildlife population could be its relative ability to 
achieve and maintain discrete, biologically feasible, recovery objectives. Recovery 
involves the identification and mitigation of threats to increase the likelihood that a 
threatened species will continue to persist in the wild (Vancouver Island Marmot 
Recovery Team, 2008). To achieve recovery there is a need for appropriate 
intervention and this needs to be supported by social and political will, adequate 
resources, and technical wherewithal. Therefore, an endangered species’ current and 
future health also is dependent upon the presence or absence of tangible remedial 
actions and upon the logistical feasibility of implementing them. 
The descriptive component of health incorporates the empirical, bio-statistical 
elements of health and health surveillance (Hanisch et al. 2012). This includes the 
establishment of baseline parameters to delineate what is normal or expected for a 
species, how these measures compare between populations exposed to different 
conditions, and how they reflect on the wellness and population viability of the 
species in question (Vitali et al, 2011). These parameters should be monitored over 
time to identify how they change in response to existing conditions (which may be 
indicative of health deterioration and reduced coping capacity) or to new stresses or 
challenges. 
 
THE VANCOUVER ISLAND MARMOT 
As both its common and scientific names suggest, the Vancouver Island 
Marmot (VIM) is a species that is endemic to the insular mountains of Vancouver 
Island (Swarth, 1912; Swarth, 1911). This large, fossorial sciurid naturally inhabits 
small, moderately to steeply sloped, south to west facing subalpine meadows 
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between 1000 and 1450 metres elevation (Bryant and Janz 1996). Within recent 
historical times (i.e. within the last century) its range has extended from several 
mountains to the immediate north of Lake Cowichan (Latitude 48.94 N, Longitude 
124.16 W) on south-central Vancouver Island to Mount Schoen (Latitude 50.16 N, 
Longitude 126.23 W) which lies approximately 200 kilometers to the northwest (Janz 
et al. 2000) (Figure 1.1). 
Due to the low numbers of VIM, limited available natural habitat, restricted 
geographical range, and endemic status, the species was first listed as endangered in 
1978 by the Committee on the Status of Endangered Wildlife in Canada (COSEWIC 
1979). Currently, the marmot is listed as critically endangered by the International 
Union for the Conservation of Nature’s (IUCN) Red List. It also receives legal 
protection under the federal Species at Risk Act (SARA), the British Columbia 
Wildlife Act, and the United States Endangered Species Act (Vancouver Island 
Marmot Recovery Team, 2008). 
Field inventory conducted in the early to mid-1980s, concentrating primarily 
in the Nanaimo Lakes region (identified as the “core” area for marmots - which 
encompasses mountains to the north and north-west of Lake Cowichan and to the 
east and north-east of the Alberni Inlet) determined that there were approximately 
300 to 350 marmots in existence and that the population was stable or increasing. 
However, beginning in the late 1980s and throughout the 1990s, VIM numbers 
demonstrated precipitous and progressive declines (Bryant & Page, 2005). By 1998 
the wild population had been reduced to less than 100 individuals and by 2003 it 
was less than 30 (Jackson et al. 2015; Janz et al. 2000). 
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Figure 1.1. Historical distribution of the Vancouver Island Marmot (Marmota vancouverensis), from the time it was first scientifically collected by 
Harry Swarth in 1910 up to the early 2000s, prior to intensive reintroduction efforts which began in 2003. The elipses delineate the two geographically 
distinct metapopulations that have been delineated for species recovery; (1) Nanaimo Lakes and (2) Strathcona Park / Mount Washington. Two 
other sites, (3) Mount Cain  and (4) Steamboat Mountain on the Clayoquot Plateau are locations of extralimital, assisted colonization. Map prepared 
by A.A. Bryant and adapted from the 2000 Update of the National Recovery Plan for the V.I. Marmot 
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In the early 1980s it was first determined that a significant portion of the 
marmot population had recently become established in higher tracts of logged 
habitat (at elevations above 700 meters) that in the early stages of seral succession, 
mimicked the characteristics of the marmots’ natural subalpine meadows. However, 
rapid regeneration of conifers and alders at these sites altered the formerly meadow-
like habitat, making them unsuitable for the colonizing marmots. Increased tree 
cover may also have served to increase the stalking advantages for Cougars (Puma 
concolor). The increased open habitat created by logging may have facilitated an 
increase in Golden Eagle (Aquila chrysaetos) numbers and extensive logging roads 
may have acted as travel corridors for Grey Wolves (Canis lupus), thereby increasing 
their access and contact with marmots who commonly used these same roads as 
burrowing substrate. Increased vulnerability to predation from these naturally- 
occurring predators may have resulted in marmot declines at these anthropogenic, 
ephemeral sites (Aaltonen et al. 2009). This resulted in a typical pattern of cut-block 
colonization and population growth, followed by colony attrition, collapse and 
eventual extirpation (Bryant, 1996).  
Most colonies in logged habitat became established in close proximity to 
natural colonies, which started to exhibit parallel declines, and in many cases, 
extirpation. It is possible that the logged areas disrupted colony connectivity, genetic 
exchange and “rescue” of natural colonies by intercepting dispersing marmots, thus 
interfering with the natural mechanisms that had traditionally perpetuated the 
marmots’ meta-population (Bryant, 1998). Altered predator-prey relationships on 
Vancouver Island, including declines in Black-tailed Deer (Odocoileus hemionus), may 
have also led to increased predation pressure that affected marmots in both natural 
and logged habitat (Bryant and Page, 2005). 
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Limited historical data exists for the populations in Strathcona Park and 
Forbidden Plateau, which lie to the northwest of the Alberni Inlet. It is believed that 
these populations declined over the last few decades, leaving only a single extant 
colony inhabiting the artificially managed ski-runs at Mount Washington (Bryant, 
1998). These northern sites were not under the same development pressures as the 
southern “core” and the proximate causes of marmot declines in these areas and in 
the Beaufort Range, which connected the north-west and south-east populations, 
have not been well established. 
There is compelling paleontological and archaeological evidence to suggest 
that this species was once more widespread on Vancouver Island and that its 
subsequent range contraction was not entirely related to modern anthropogenic 
influences (Nagorsen et al. 1996). 
 
MARMOT RECOVERY AND CURRENT STATUS   
Based upon extremely low numbers and ongoing population declines, the 
2000 National Recovery Plan concluded that although sufficient natural habitat 
remained, recovery efforts involving only in situ management were unlikely to save 
the species from extinction. This document stated that “few animals exist for 
reintroductions or other management activities” and that “it is unlikely that wild 
populations will suddenly rebound of their own accord (and therefore) Captive breeding 
and reintroduction present the only chance of increasing populations within a reasonable 
period of time and minimizing the risk of extinction”.  
As a result of these determinations, an intensive captive breeding program 
was initiated for this species in 1997, with the intention of (i) establishing a 
safeguard against potential catastrophic or stochastic events in the wild, (ii) acting as 
a long-term genetic reservoir, (iii) determining appropriate management and 
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husbandry techniques for the successful captive maintenance and propagation of 
Vancouver Island Marmots, (iv) conducting directed research, and (v) providing 
sufficient numbers of individuals for release and eventual restoration of the wild 
population (Janz et al. 2000). Since its inception, this ex situ program has involved the 
participation of three zoological institutions, the Toronto Zoo (TZ), the Calgary Zoo 
(CZ), and the Mountain View Conservation and Breeding Society in Langley, British 
Columbia (MVF) along with the construction of a dedicated $1.2 million marmot 
facility at Mount Washington on Vancouver Island, the Tony Barrett Mount 
Washington Marmot Recovery Centre (MRC).  
The VIM captive breeding program reached its numerical peak in 2008 with 
177 marmots and 46 breeding pairs. From 2009 to 2015 the program was 
intentionally down-sized due to diminishing resources and some early 
reintroduction success (Jackson et al. 2015). Subsequent declines in the wild 
population following 2012 have prompted a recent restoration of the captive 
program. As of December 2017, the captive population consists of 49 surviving 
marmots, including 12 breeding pairs. Overall, there has been a total of 660 
individual marmots maintained in captivity, including 63 marmots originally 
captured from the wild and 597 captive-born marmots. One hundred and twelve 
mortalities have occurred in captivity and a total of 501 marmots (8 wild-born, 493 
captive-born) have been released back to the wild (Vancouver Island Marmot 
Captive Management Group, 2017).  Releases include 167 captive individuals into 
the Nanaimo Lakes area, 187 into Strathcona Park, 109 to Mount Washington, 16 into 
the Clayoquot Plateau Provincial Park, and 22 into the Mount Cain / Mount Schoen 
area. 
Based upon historical occurrence records, the estimated carrying capacity of 
suitable habitat patches, and population simulation models, recovery for the 
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Vancouver Island marmot was initially defined as a self-sustaining wild population 
of 400 to 600 marmots, distributed in three geographically separate meta-
populations on Vancouver Island (Vancouver Island Marmot Recovery Team, 2008; 
Janz, et al. 2000). The potential existence of three independent meta-populations, 
identified as (i) the Nanaimo Lakes region, (ii) western Strathcona Park and (iii) 
Mount Washington / Forbidden Plateau, would likely serve to reduce the 
population’s vulnerability to stochastic or localized threats, and were delineated by 
the presence of large water bodies, primarily the Alberni Inlet and Buttle Lake, that 
would act as barriers to dispersing marmots. Due to the potential for habitat 
connectivity recently identified along the southern end of Buttle Lake, the western 
Strathcona Park and Mount Washington / Forbidden Plateau were deemed to be a 
single recovery population in the 2017 Recovery Strategy. Based upon the 
limitations imposed by a discrete numerical recovery goal (i.e. one without a 
temporal component), this strategy also re-defined marmot recovery as both 
geographically distinct meta-populations having a greater than 90% probability of 
persisting for over 100 years, without augmentation from the captive program 
(Vancouver Island Marmot Recovery Team, 2017; Jackson et al. 2015).  
Although there has been some population restoration from its low point in 
2003, the VIM continues to be managed by an intensive program involving captive 
breeding, reintroductions, and translocations. At the end of the 2017 field season 
population estimates were 70 to 80 individuals in the Nanaimo Lakes meta-
population, 70 to 80 in the Strathcona Park meta-population (including Mount 
Washington), and an unknown number surviving within Clayoquot Plateau 
Provincial Park, and at Mount Seth in Schoen Lake Provincial Park. The total wild 
population is currently estimated to be approximately 150 individuals (Vancouver 
Island Marmot Recovery Team, November 2017). 
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Figure 1.2.  Annual total of individuals in the Vancouver Island Marmot (Marmota vancouverenesis) population from 1997 
to 2017.  
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THESIS STRUCTURE 
For the foreseeable future, the critically endangered VIM will be managed by 
an intensive program of captive breeding and conservation translocations. Low 
numbers and artificial manipulation pose potential risks that could negatively 
impact individual and population health and could prevent this species from 
achieving recovery objectives. Effective health monitoring and a better 
understanding of normality or baseline characteristics, and identification of possible 
threats, is essential for the successful long-term conservation of this species. This 
recovery program has gathered a great range of health information from the 
marmots’ wild, captive, and captive-release populations. Without further collation 
of these disparate data, their usefulness for future research, learning, comparison, 
evidence-based decisions, and management will not be fully realized. In this thesis I 
compile and analyse these data by describing and evaluating select health 
parameters. Individual condition indices (hematology and serology, chapter two), 
clinical assessments (physical examinations, chapter three), and health outcomes 
(morbidity and mortality, chapter three) are used to establish and compare baseline 
health characteristics for the VIM under different treatments (wild, captive and 
captive-release) and to identify possible health threats. This information can be used 
in the future to recognize changes in VIM health and to guide management 
decisions.  
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CHAPTER 2  
HEMATOLOGICAL AND SERUM BIOCHEMICAL PARAMETERS 
IN THE VANCOUVER ISLAND MARMOT (MARMOTA VANCOUVERENSIS):  
REFERENCE RANGES AND A COMPARISON OF VALUES BETWEEN MANAGEMENT 
GROUPS  
 
INTRODUCTION 
The Vancouver Island marmot (Marmota vancouverensis) is a critically 
endangered member of the family Sciuridae, endemic to the subalpine meadows of 
central Vancouver Island, located off the southwest coast of British Columbia, 
Canada (Swarth, 1912; Swarth, 1911). In the late 1980s this rare species started to 
exhibit serious population declines (Bryant & Page, 2005). By 1998 marmot numbers 
had dropped below 100, and by 2003 there were fewer than 30 wild individuals 
(Jackson et al. 2015; Janz et al. 2000). In response to this dramatic attrition, a 
concerted captive breeding and reintroduction program was initiated in 1997. Since 
its inception, this program has included the participation of the Toronto Zoo (TZ, 
1997 to present), the Calgary Zoo (CZ, 1998 to present), and the Mountain View 
Conservation and Breeding Society in Langley, British Columbia (MV, 2000 to 2014). 
In 2001 a purpose-built, quarantine and breeding facility, the Tony Barrett Mount 
Washington Marmot Recovery Centre (MRC), became operational at Mount 
Washington, Vancouver Island. 
As of December 2017, 660 marmots have been associated with the captive 
program, including 63 wild-born individuals originally captured for breeding 
purposes and 597 marmots born and weaned in captivity. Reintroductions of captive 
animals began in 2003 and by 2017 a total of 501 marmots (8 of the original wild-
born and 493 of the captive-born) or 75.9% of the overall captive total, have been 
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released to the wild. Although these recovery efforts have helped to increase the 
wild population from its low point in 2003, conservation of the Vancouver Island 
Marmot (VIM) continues to involve an intensive program of ex situ management, 
reintroductions, and translocations (Vancouver Island Marmot Recovery Team, 
2017). 
The health of an endangered species like the VIM can be negatively affected 
by many biotic and abiotic factors, including environmental perturbations, low 
population numbers, and artificial manipulation (Jackson et al. 2015; Moorhouse et 
al., 2006). Although monitoring health and changes in health is important for the 
vigilent recognition, ellucidation, and mitigation of potential threats that may 
jeopardise species viability and recovery, effective health surveillence represents a 
significant challenge for conservation programs (Jackson et al. 2015; Robert & 
Schwanz, 2013; Delahay et al., 2009; Miller, 2007; Daszak, et al. 2001; Snyder, et al. 
1996).  
Many studies characterising wildlife health have emphasized dysfunction, 
pathogens, and mortality in populations (Ryser-Degiorgis, 2013). However, the 
ability to recognize and contextualize abnormality or disease requires an 
appreciation of ‘normal’ (Dimauro, et al., 2008). Baseline measurements of health 
parameters, often lacking in many wildlife species (Maceda-Veiga, et al., 2015), can 
be used to delineate variability and to compare what is expected for a species under 
different management regimes. This in turn may identify determinants and possible 
risk factors that are influencing health in individuals and populations (Hanisch, et al. 
2012; Vitali et al., 2011; Mathews et al., 2006; Deem et al. 2001). A wide variety of 
morphological, physiological, biochemical, and condition indices have been used to 
quantify health and fitness at both the individual and population level (Peig & 
Green, 2009; Stevenson & Woods, Jr., 2006; Wisely, et al., 2005). This includes 
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hematology and serum biochemistry, which have been used to describe and 
compare physiological state, adaptation to different habitat conditions, nutritional 
status, body condition, organ function, relative stress, immune status, biological 
integrity, the presence of infectious or non-infectious disease, inflammation, and 
parasite burdens (Ruykys et al., 2012; Mellish et al., 2010; Moorhouse et al., 2007; 
Masello & Quillfeldt, 2004). 
In this project, VIM hematology and serum biochemistry metrics were 
analysed to delineate expected values and their range of variability in clinically 
normal animals. Hematology and serology parameters also were compared between 
different management conditions (wild, captive and captive-release, un-implanted 
and implanted). The goals of this project were to compile the first set of hematology 
and serum reference values for the VIM and assess the potential role of these 
parameters for comparing and monitoring health in this species. 
 
MATERIALS AND METHODS 
Classification of marmot management groups 
1. Captive marmots were defined as any captive-born marmot originating from one 
of the four captive facilities or any wild-born marmot that had been captured for 
the captive breeding program and had therefore spent at least one hibernation in 
any of these captive facilities. 
2. Captive-release marmots were animals released to the wild from captivity, 
including those originally born in captivity and any wild-born marmot that had 
been maintained in captivity for more than a single active season prior to release.  
3. Wild marmots were wild-born individuals that had never been maintained in a 
captive facility or any wild-born marmot that had been temporarily maintained 
at the MRC for less than a single, active season and then returned to the wild. 
23 
 
 
Captive-release and wild marmots were collectively defined as free-ranging and 
with a few exceptions were surgically implanted with a very high frequency 
(VHF) radio-transmitter (Appendix E). 
Classification of marmot ages 
Marmot ages were categorized as young-of-the-year (pups or juveniles in 
their first summer), yearling (individuals in their second summer), two-year old 
(third summer), and adult (fourth or subsequent summers). The age of all captive-
born individuals was known with certainty. The age categories of wild-born 
marmots were known or extrapolated from previously described pelage 
characteristics (Bryant 1998) and relative size and appearance. In the field, age 
categories could be determined with relative certainty, except in the case of some 
individuals identified as two year-olds that exhibited characteristics which 
overlapped with those of yearlings and adults. Wild adults that were handled and 
identified for the first time could only be categorized as being three years of age or 
older, due to the non-specificity of their size and pelage characteristics. 
Sample collection and analysis 
Comprehensive physical examinations were conducted on all marmots at the 
time of blood collection. These examinations were conducted by a veterinarian and 
routinely involved an evaluation of the cardiovascular, respiratory, musculoskeletal, 
nervous, integumentary, and urogenital systems and an assessment of the marmot’s 
body condition. Marmots that did not display identifiable abnormalities at the time 
of examination were classified as clinically normal. For the purposes of this analysis, 
blood samples collected from captive marmots with pre-existing or newly identified 
health concerns at the time of sampling and those from quarantined, wild-caught 
marmots undergoing the chronic stress associated with transitioning to captive 
conditions (Cabezas et al., 2007), were categorized as clinically abnormal. These 
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clinically abnormal samples were excluded from calculation of the reference values 
and in analyses comparing age, sex, and management groups. They only were used 
to explore the possibility that there were group differences between clinically 
normal and abnormal animals. Samples were collected in captivity or at field sites in 
association with the following circumstances (Figure 2.1): 
A. Captive Marmots: 
i. Annual or biennial health evaluation of captive marmots maintained at 
the TZ, CZ, MV and MRC (258 individuals, 606 samples). These marmots 
did not have implanted abdominal radio-transmitters at the time of 
sampling (un-implanted).  
ii. Pre-operative evaluation of captive marmots prior to surgical 
implantation with abdominal radio-transmitters (188 individuals, 188 
samples). These marmots did not have implants at the time of sampling. 
Categories i. and ii. (healthy, un-implanted, captive marmots) represented 
the largest number of samples, accounting for 76.4% of the overall total.  
iii. Evaluation of implanted, captive-release marmots on the day of release or 
on the day that preceded it (133 individuals, 133 samples). Following 
surgery, captive, implanted marmots were afforded a period of 
convalescence in captivity before being released to the wild. The interval 
between captive surgery and release ranged from 11 to 93 days (average = 
28 days).  
iv. Examinations that identified or addressed specific health concerns in 
captive marmots (30 individuals, 44 samples). Categories of health 
concerns included congenital or early onset problems, infections / 
inflammation, heart disorders, neoplasia, and trauma. 
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v. Health evaluation of marmots during quarantine. These wild-caught 
marmots were being transitioned into the captive program (23 
individuals, 23 samples). 
Samples from (iv.) and (v.) were categorized as clinically abnormal. 
B. Free-ranging Marmots: 
vi. Evaluation of implanted, post-release marmots prior to surgical 
replacement of radio-transmitters (16 individuals, 16 samples). 
vii. Pre-operative evaluation of wild marmots prior to surgical implantation 
with abdominal radio-transmitters (66 individuals, 66 samples). Marmots 
did not have an implanted radio-transmitter at the time of sampling. 
viii. Evaluation of implanted, wild marmots prior to replacement of radio-
transmitters (14 individuals, 19 samples). 
ix. Health evaluation of implanted, wild marmots which were 
opportunistically recaptured for evaluation or translocation (11 
individuals, 11 samples). 
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Figure 2.1. Schematic diagram illustrating the relationships and sample size of the Vancouver Island Marmot 
(Marmota vancouverensis) blood sampling categories used in the analyses. “Implanted” refers to individuals with 
previously implanted radio-transmitters. The arrows indicate groups with the potential for overlap (i.e. an individual 
may have been sampled as part of a pre-surgical examination and then again prior to release, or at the time of 
recapture or radio-transmitter replacement).  
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Whole blood samples (up to 6 millilitres in volume) were obtained following 
immobilization with an intramuscular injection of ketamine hydrochloride 
combined with midazolam hydrochloride (various manufacturers) at approximately 
10 mg/kg and 0.25 mg/kg, respectively and then maintained on inhaled isoflurane. 
In some instances, marmots were mask induced with isoflurane without receiving 
any injectable immobilization agents (Graham Crawshaw, Toronto Zoo, personal 
communication). 
Blood samples were collected from the cephalic, saphenous, femoral, or tarsal 
veins. Following venipuncture, a portion of the whole blood was promptly 
transferred into a vacuum tube containing the anticoagulant ethylenediamine-tetra-
acetic acid (EDTA) and into a serum-separating vacuum tube (SST) containing gel. 
The SST samples were allowed to clot, and then centrifuged. A small portion of 
whole blood was used to make two blood smears, which were subsequently air-
dried at room temperature or in the field, at ambient temperature. Captive and field 
samples were kept cool and protected from heat, direct sunlight, and freezing 
temperatures. The data used in this analysis were derived from samples collected 
over a 23-year period from marmots at geographically disparate locations. Because 
of lab changeover and logistical practicalities, samples were submitted to one of four 
diagnostic laboratories; the in-house laboratory at the Toronto Zoo (n=122), Central 
Laboratory for Veterinarians in Calgary, Alberta or Langley, British Columbia 
(combined, n=648) and Idexx Reference Laboratories in Delta, British Columbia 
(n=268). Ninety-eight per cent or 1,084 of the submitted samples were analyzed 
within three days of collection.  
The 16 hematological parameters included total white blood cells (WBC), red 
blood cells (RBC), hemoglobin (Hb), hematocrit (HCT), mean corpuscular volume 
(MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin 
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concentration (MCHC), red cell distribution width (RDW), platelet count, mean 
platelet volume, segmented neutrophils, band neutrophils, lymphocytes, monocytes, 
eosinophils and basophils. The 30 serological parameters included glucose, blood 
urea nitrogen (BUN), creatinine, BUN / creatinine ratio, sodium (Na), potassium (K), 
sodium / potassium ratio, chloride (Cl), bicarbonate, carbon dioxide, anion gap, 
calcium, phosphorous (P), calcium / phosphorous ratio, total protein, albumin, 
globulin, albumin / globulin ratio (A/G ratio), total bilirubin, alkaline phosphatase 
(ALP), alanine amino transferase (ALT), aspartate amino transferase (AST), gamma 
glutamyl transferase (GGT), creatinine phosphokinase (CK), calculated osmolality, 
lactose dehydrogenase (LDH), amylase, lipase, cholesterol and tetra iodothyronine.  
In keeping with management activities, all blood samples were collected 
during the marmots’ active season. Although the blood parameters of other true 
hibernators have been found to exhibit changes during hibernation, including 
decreases in leukocytes, total bilirubin, glucose, and creatinine, and increases in total 
protein and albumin (Feoktistova et al., 2016), these trends could not be investigated 
with the availible data. Free-ranging marmots were not accessible for sampling 
during the hibernation period. Although there was the potential to sample captive 
marmots, which were allowed to hibernate as a standard management protocol, this 
did not occur due to concerns about prolonged clotting times associated with 
physiological changes during torpor, such as thrombocytopenia (Cooper et al., 2012).  
Baseline reference values were calculated in accordance with guidelines 
established by Species 360 (formerly the International Species Information System), 
which incorporate several steps to minimize the potential influence of multiple 
laboratories and repeated sampling of the same individuals (Teare, 2002). In 
accordance with these guidelines, the mean and standard deviation are calculated 
for each of the hematological and serological variables generated from clinically 
29 
 
 
normal or healthy animals.  The standard deviation for these variables was 
multiplied by three, and the resulting value (representing 3 standard deviations or 
99.7% of the values) was subtracted and added to the calculated mean. Any values 
lying outside this calculated lower and upper range were deemed to be outliers and 
were removed. The mean and standard deviation were then re-calculated without 
the outliers (Teare, 2002; de With et al., 1999). For the VIM baseline reference values, 
all clinically normal marmots from all groups, including captive, captive-release, 
and wild (inclusive of implanted and non-implanted animals) were included in the 
analysis.   
Subsequent analyses focused on comparing the major management groups, 
specifically wild, captive, and captive-release marmots. Values for clinically normal 
marmots without abdominal radio-transmitters were compared to clinically normal, 
implanted marmots and to values for marmots in the clinically-abnormal group. 
Data were visually examined using dot plots and box plots to identify potential 
trends or differences with respect to marmot age, sex, and season.     
Statistical analyses were performed using R (version 3.3.1, R Development 
Project, https://www.r-project.org). Normality of data distribution was assessed 
visually using histograms. Statistical comparison of parameters was performed 
using Student’s unpaired t-test. All tests were two-tailed and statistical significance 
was assigned at α = 0.01.   
 
RESULTS 
From August 1992 to June 2015, 1,106 blood samples were opportunistically 
collected from 439 (243 males, 196 females) captive, captive-release, and wild VIM. 
Individual marmots were sampled between 1 and 14 times. The overall average was 
2.52 samples per individual marmot. The sampling mean for captive marmots was 
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2.85 (range 1 to 14) and for wild individuals it was 1.06 (range 1 to 4). Sixty-seven of 
the samples were categorized as clinically abnormal. The remaining 1,039 blood 
samples were obtained from a total of 429 individual marmots determined to be 
clinically normal or healthy at the time of sampling. Blood sample distribution with 
respect to year of collection is presented in Figure 2.2. The blood samples were 
collected over a 23 year-period, indicating the potential for differences with respect 
to technicians, laboratories and analytical techniques over time. Monthly 
distribution of sample collection is presented in Figure 2.3. All blood samples were 
collected during the marmots’ active season with over 90% being obtained between 
June and September. Most of the routinely scheduled annual or biennial health 
evaluations of captive marmots, which represented the largest category of blood 
samples, occurred in September, and this is reflected in the graph.  
The sex-age distribution of sampled marmots is presented in Figure 2.4. 
Although there is relatively comparable representation of males and females, the 
sample set was biased towards younger individuals. The age distributions of free-
ranging and captive samples are compared in Figure 2.5. The greater longevity and 
accessibility of captive marmots allowed more opportunities for collection of blood 
samples from older animals, in contrast to their free-ranging counterparts 
Hematology and serum biochemistry reference values derived from all 
clinically normal VIM and following Species 360 guidelines are presented in Tables 
2.1 and 2.2. The means of VIM reference values are compared to values that have 
been generated for other small to medium sized rodents in Table 2.3. The general 
characteristics of the VIM reference ranges appear to be qualitatively comparable to 
values that have been generated for these other species of rodents.  
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Figure 2.2. Annual distribution of 1,106 blood samples collected from Vancouver 
Island Marmots (Marmota vancouverensis) 1992 to 2015.  
 
 
 
 
Figure 2.3. Monthly distribution of 1,106 blood samples collected from captive 
and free-ranging Vancouver Island Marmots (Marmota vancouverensis).  
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Figure 2.4. Sex and age distribution of 1,106 blood samples collected from captive 
and free-ranging Vancouver Island Marmots (Marmota vancouverensis). 
 
 
 
Figure 2.5. Comparison of age distribution of 1,106 blood samples collected from 
captive and free-ranging Vancouver Island Marmots (Marmota vancouverensis). 
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Table 2.1. Reference intervals for 16 hematological parameters from clinically 
healthy Vancouver Island Marmots (Marmota vancouverenis).  
 
Parameter Units Mean Min Max N S.D. 
WHITE BLOOD CELLS             
White blood cells x 10⁹/L 4.96 0.60 12.20 1018 1.89 
Segmented neutrophils x 10⁹/L 2.64 0.25 7.56 1017 1.20 
Band neutrophils x 10⁹/L 0.00 0.00 0.00 1012 0.00 
Lymphocytes x 10⁹/L 1.93 0.01 5.55 1018 1.13 
Monocytes x 10⁹/L 0.31 0.00 1.40 1012 0.25 
Eosinophils x 10⁹/L 0.03 0.00 0.25 1011 0.05 
Basophils x 10⁹/L 0.01 0.00 0.12 1003 0.02 
ERYTHROCYTES             
Red blood cells x 10 ¹²/L 6.44 4.2 8.49 1010 0.63 
Hemoglobin g/L 145.10 98 187 1004 14.32 
Hematocrit L/L 0.43 0.29 0.557 1021 0.04 
Mean corpuscular 
volume  
fl 65.90 50 82.3 977 3.51 
Mean corpuscular 
hemoglobin 
pg 22.44 16.3 33.1 986 1.60 
Mean corpuscular 
hemoglobin 
concentration 
g/L 339.29 294 384 983 12.26 
Red cell distribution 
width 
%CV 14.35 10.1 20.3 877 1.52 
HEMOSTASIS             
Platelet count x 10⁹/L 318.70 37 625 761 91.68 
Mean platelet volume fl 8.91 6.7 14 694 1.26 
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Table 2.2. Reference intervals for 30 serum biochemistry parameters from 
clinically healthy Vancouver Island Marmots (Marmota vancouverensis). 
  
Parameter Units Mean Min Max N S.D. 
ELECTROLYTES AND 
ACID-BASE 
            
Sodium mmol/L 143.84 130 155.8 525 4.05 
Potassium mmol/L 5.37 3.3 13.3 522 1.42 
Sodium / Potassium 
ratio 
ratio 28.14 8.6 43.6 525 6.08 
Chloride mmol/L 102.11 88 112 528 4.11 
Bicarbonate mmol/L 26.37 9 39 147 5.88 
Carbon Dioxide mmol/L 26.37 5 38 357 5.60 
Anion Gap  20.71 6 41 512 6.56 
Calcium mmol/L 2.39 1.44 3.33 598 0.21 
Phosphorous mmol/L 1.83 0.66 3.48 594 0.47 
Calcium / Phosphorous 
ratio 
ratio 1.39 0.44 4.25 573 0.41 
Calculated Osmolality mmol/kg 297.25 276 319 508 6.73 
PROTEINS             
Total Protein g/L 61.97 42 90 643 8.97 
Albumin g/L 27.30 17 43 555 3.56 
Globulin g/L 32.85 18.6 53 553 6.03 
Albumin / Globulin ratio ratio 0.86 0.3 1.9 561 0.20 
LIVER AND MUSCLE             
Total Bilirubin μmol/L 2.63 0 7 428 1.37 
Alkaline Phosphatase IU/L 71.58 5 266 556 41.35 
Alanine 
Aminotransferase  
IU/L 18.64 1 117 512 16.97 
Aspartate 
Aminotransferase 
IU/L 37.08 1 222 449 34.51 
Gamma 
Glutamyltransferase 
IU/L 3.96 0 18 516 3.01 
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Table 2.2. (cont.) Reference intervals for 30 serum biochemistry parameters from 
clinically healthy Vancouver Island Marmots (Marmota vancouverensis). 
  
Parameter Units Mean Min Max N S.D. 
LIVER AND MUSCLE             
Creatinine 
Phosphokinase 
IU/L 526.24 56 2970 583 366.23 
Cholesterol  mmol/L 7.24 3.71 13.05 72 1.98 
Glucose mmol/L 8.78 2.2 15.8 630 2.29 
RENAL FUNCTION             
Blood Urea Nitrogen mmol/L 10.92 3.1 22.2 632 2.60 
Creatinine μmol/L 81.91 18 150 617 21.80 
Bun / Creatinine ratio ratio 0.14 0.025 0.376 613 0.06 
OTHER       
Lactose Dehydrogenase IU/L 1784.97 865 4068 30 822.29 
Amylase IU/L 839.79 147 2086 77 423.02 
Lipase IU/L 191.79 60 856 73 137.25 
Tetra Iodothyronine nmol/L 57.17 20 91 151 16.82 
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Table 2.3. Vancouver Island Marmot (Marmota vancouverenis) hematological and 
serological mean values compared to published means for the Woodchuck 
(Bellezza, et al., 2015) and normal values published for Mice (Mus musculus), Rats 
(Rattus norvegicus), Gerbils (Meriones unguiculatus), and Guinea Pigs (Cavia 
porcellus) (Harkness & Wagner, 1995).  
 
 
Parameter Units 
VIM        
mean 
Woodchuck                      
low / high mean 
(a) 
Mouse 
range 
Rat                        
range 
Gerbil                          
range 
Guinea 
Pig                   
range 
WHITE BLOOD CELLS               
White blood cells x 10⁹/L 5 8.7 / 10.4 6 - 15 6 - 17 7 - 15 7 - 18 
Segmented neutrophils  % 53 63 (b) 10 - 40 9 - 34 5 - 34 28 - 44 
Lymphocytes  % 39 26 (b) 55 - 95 65 - 85 60 - 95 39 - 72 
Monocytes  % 6 6 (b) 0.1 - 3.5 0 - 5 0 -3 3 - 12 
Eosinophils % 0.6 4 (b) 0 - 4 0 - 6 0 - 4 1 - 5 
Basophils % 0.2  0 - 0.3 0 - 1.5 0 - 1 0 - 3 
ERYTHROCYTES               
Red blood cells x 10 ¹²/L 6.4 4.7 / 5.3 7.0 - 12.5 7 - 10 8 - 9 4.5 - 7 
Hemoglobin g/L 145 122 / 132 102 - 166 110 - 180 126 - 162 110 - 150 
Hematocrit L/L 0.43 0.36 / 0.41 0.39-0.49 0.36-0.48 0.43-0.49 0.37-0.48 
Mean corpuscular volume fl 66 73 / 77      
Mean corpuscular 
hemoglobin 
pg 22 25 / 26      
Mean corpuscular 
hemoglobin concentration 
g/L 340 340 / 360      
Red cell distribution width %CV 14 14 / 17.5      
 
(a) High and low means arising from multiple studies as reported in Bellezza, et al., 2015 
 
(b) Published values in which the collective mean of the differential count equals the mean of the total 
white blood cells   
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Table 2.3. (cont.) Vancouver Island Marmot (Marmota vancouverenis) 
hematological and serological mean values compared to published means for the 
Woodchuck (Bellezza, et al., 2015) and normal values published for Mice (Mus 
musculus), Rats (Rattus norvegicus), Gerbils (Meriones unguiculatus), and Guinea 
Pigs (Cavia porcellus) (Harkness & Wagner, 1995).  
 
Parameter Units 
VIM        
mean 
Woodchuck                      
low / high mean 
(a) 
  
Mouse 
range 
Rat                        
range 
Gerbil                          
range 
Guinea 
Pig                   
range 
HEMOSTASIS               
Platelet count x 10⁹/L 319 451 / 525 800-1100 500-1300 400 - 600 250 - 850 
Mean platelet volume fl 8.9 6.8 / 7.1      
ELECTROLYTES AND ACID-
BASE 
              
Sodium mmol/L 144 143 / 151 112 - 193 135 - 155 144 - 158 132 - 156 
Potassium mmol/L 5.4 3.7 / 4.7 5.1 - 10.4 4 - 8 3.8 - 5.2 4.5 - 8.9 
Sodium / Potassium ratio ratio 28 34 / 40      
Chloride mmol/L 102 97 / 102 82 - 114 94 - 116 93 - 118 98 - 115 
Bicarbonate mmol/L 26 30 / 34      
Carbon Dioxide mmol/L 26 31 / 34      
Anion Gap  20 15 / 20      
Calcium mmol/L 2.4 2.3 / 2.6 0.8 - 2.1 1.3 - 3.2 0.9 - 1.6 1.3 - 3.0 
Phosphorous mmol/L 1.8 1.2 / 1.7 0.7 - 3.0  1.7 - 2.7  1.2 - 2.3 1.0 - 3.9 
PROTEINS               
Total Protein g/L 62 55 / 69 35 - 72 56 - 76 43 - 125 46 - 62 
Albumin g/L 27 23 / 37 25 - 48 38 - 48 18 - 55 21 - 39 
Globulin g/L 33 30 / 36 6 18 - 30 12 - 60 17 - 26 
Albumin / Globulin ratio ratio 0.9 0.7 / 1.1      
 
(a) High and low means arising from multiple studies as reported in Bellezza, et al., 2015 
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Table 2.3. (cont.) Vancouver Island Marmot (Marmota vancouverenis) 
hematological and serological mean values compared to published means for the 
Woodchuck (Bellezza, et al., 2015) and normal values published for Mice (Mus 
musculus), Rats (Rattus norvegicus), Gerbils (Meriones unguiculatus), and Guinea 
Pigs (Cavia porcellus) (Harkness & Wagner, 1995).  
 
Parameter Units 
VIM        
mean 
 
Woodchuck                      
low / high mean 
(a)  
Mouse 
range 
Rat                        
range 
Gerbil                          
range 
Guinea 
Pig                   
range 
LIVER AND MUSCLE               
Total Bilirubin μmol/L 2.6 1.9 / 5.5 1.71-15.4 3.4 - 9.4 3.4 - 10.3 5.1 - 15.4 
Alkaline Phosphatase IU/L 72 7.2 / 19.3 45 - 222 16 - 125 12 - 37 18 - 28 
Alanine Aminotransferase  IU/L 19 1.0 / 3.5 26 - 77 16 - 89  10 - 25 
Aspartate Aminotransferase IU/L 37 21 / 34 54 - 269 192 - 262  45.5-48.2 
Gamma Glutamyltransferase IU/L 4 1.7 (b)      
Creatinine Phosphokinase IU/L 526 478 / 690      
Cholesterol  mmol/L 7.2 3.6 / 5.4 0.7 - 2.1 1 - 3.4 2.3 - 3.9 0.5 - 1.1 
Glucose mmol/L 8.8 10.2 / 12.1 3.4 - 9.7 2.8 - 7.5 2.8 - 7.5 3.3 - 7 
RENAL FUNCTION               
Blood Urea Nitrogen mmol/L 11 4.6 / 9 4.3 - 10 5.4 - 7.5 6 - 9.6 3.2 - 11.3 
Creatinine μmol/L 82 79.5 / 133 26 - 88 18 - 71 53 - 124 53 - 194 
OTHER               
Amylase IU/L 840 2210 / 2645      
Lipase IU/L 192 201 / 361         
 
(a) High and low means arising from multiple studies as reported in Bellezza, et al., 2015 
 
(b) One mean reported in Bellezza, et al., 2015 
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Seasonal Trends. Total white blood cells, neutrophils, lymphocytes, monocytes, total 
protein and albumin increased during the course of the active season (Figure 2.6), 
while platelet count, total bilirubin, glucose and creatinine did not exhibit change. In 
laboratory Woodchucks (Marmota monax), the hematocrit has been reported to be 
higher in the spring than in the autumn (Bellezza, et al., 2015), but this was not 
apparent from these data. Woodchucks and Yellow-bellied Marmots (Marmota 
flaviventris), also are reported to have an increase in red blood cells, hematocrit, and 
hemoglobin from early to late summer in preparation for hibernation (Armitage, 
2014). VIM exhibited a similar trend in all three parameters from June to October, 
but the magnitude of the difference was relatively small (Figure 2.7).   
Age trends. Red blood cells, hematocrit, and hemoglobin appeared to decline with 
marmot age (Figure 2.8) whereas the leukogram (including total white blood cells, 
neutrophils, lymphocytes, monocytes, eosinophils, and basophils) showed no age 
pattern. Glucose decreased with age whereas amylase increased with age (Figure 
2.9).  
Elevation trends. Acclimatization to lower elevations has resulted in decreased 
hematocrit levels in Yellow-bellied Marmots (Armitage, 2014). The mean of 
hematocrit values from captive marmots maintained at the MV (elevation 25 meters) 
were 5.5, 5.6, and 7.6% lower than respective values from the CZ (elevation 1027 
meters), TZ (elevation 145 meters), and the MRC (elevation 1244 meters), and these 
differences were statistically significant (P < 0.0001). However, there was no 
significant difference or discernable elevation trend between the other three 
institutions and this could indicate that the MV values are the result of some facility 
effect rather than elevation. 
Sex trends. In several species, female hematocrit values are lower than those of 
males (Probst, et al., 2006). A sex difference in hematocrit was seen in these data and 
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was statistically significant (male mean = 0.434, female mean = 0.416, P < 0.0001). 
Amylase was lower in males than females (male mean = 711.11, female mean = 
933.10, P = 0.0408) (Figure 2.10). There was no apparent or statistically-significant sex 
difference with respect to white blood cells (P = 0.4014) or glucose (P = 0.1779). 
Group comparisons. Parameters for clinically normal captive, wild, and captive-
release marmots are compared in Tables 2.4 and 2.5. Values for non-implanted, 
implanted, and clinically abnormal marmots are compared in Table 2.6 and 2.7.  The 
statistical and clinical significance of differences between hematology and serum 
biochemistry parameters with respect to specific groups are summarised in Table 2.8 
and 2.9.  
Eleven of the 46 parameters showed no clinical or statistical differences 
between any of the groups that were compared, including values which were 
derived from clinically abnormal animals. This included 2 hematology parameters; 
band neutrophils and eosinophils, and 9 serum parameters; anion gap, calcium, 
calculated osmolality, aspartate aminotransferase, gamma glutamyltransferase, 
creatinine phosphokinase, BUN / creatinine ratio, lactose dehydrogenase (data 
limited for some groups), and lipase (data limited for some groups).  
Twenty-eight of the 46 parameters showed evidence of statistically significant 
differences between certain groups, but the small magnitude and nature of these 
differences did not suggest physiological or clinical significance.  
Eight of the 46 parameters had biologically plausible and statistically 
significant differences between some of the compared groups (Table 2.8). This 
included 5 leukogram parameters; white blood cells, segmented neutrophils, 
lymphocytes, monocytes, basophils, and 3 serum biochemistry parameters; total 
protein, albumin, and globulin. Potentially significant differences in leukogram and 
protein parameters occurred between the captive and free-ranging groups (both 
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wild and captive-release). Also, leukogram parameters of clinically normal, un-
implanted marmots differed from the clinically abnormal group.    
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Figure 2.6. Changes in total white blood cells and total protein from April to October for clinically normal 
Vancouver Island Marmots (Marmota vancouverensis).   
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Figure 2.7. Boxplot comparisons of red blood cells and hemoglobin between June and October for clinically 
normal Vancouver Island Marmots (Marmota vancouverensis).  
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Figure 2.8. Change in red blood cells and hemoglobin for clinically normal Vancouver Island Marmots 
(Marmota vancouverensis) according to age.  
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Figure 2.9. Change in glucose and amylase for clinically normal Vancouver Island Marmots (Marmota 
vancouverensis) according to age.   
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Figure 2.10. Boxplots comparing male and female values for hematocrit and amylase in Vancouver Island 
Marmots (Marmota vancouverensis).  
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Table 2.4. Hematology values comparing healthy captive (un-implanted), wild 
and captive-release Vancouver Island Marmots (Marmota vancouverensis). Bold 
indicates comparisons with statistical and potential clinical significance (a).  
 
Parameter Units 
Captive     
Mean  
S.D. N 
Wild 
mean 
S.D. N 
Captive-
release 
mean 
S.D. N 
WHITE BLOOD CELLS                     
White blood cells x 10⁹/L 5.506 2.619 601 4.401 2.376 94 3.825 1.000 16 
Segmented neutrophils x 10⁹/L 2.949 1.803 598 2.973 1.805 94 2.841 0.808 16 
Band neutrophils x 10⁹/L 0.004 0.032 598 0.000 0.000 94 0.000 0.000 16 
Lymphocytes x 10⁹/L 2.102 1.268 598 1.161 0.992 94 0.618 0.204 16 
Monocytes x 10⁹/L 0.404 0.415 598 0.194 0.164 94 0.304 0.454 16 
Eosinophils x 10⁹/L 0.034 0.074 598 0.049 0.090 94 0.031 0.045 16 
Basophils x 10⁹/L 0.016 0.038 598 0.010 0.021 94 0.028 0.037 16 
ERYTHROCYTES                     
Red blood cells x 10 ¹²/L 6.38 0.789 597 6.32 0.613 94 6.28 0.530 16 
Hemoglobin g/L 145.206 17.999 587 146.36 14.308 94 145.00 12.329 16 
Hematocrit L/L 0.43 0.048 601 0.43 0.043 94 0.43 0.039 16 
Mean corpuscular volume fl 66.356 4.782 564 67.93 2.752 94 68.63 2.752 16 
Mean corpuscular hemoglobin pg 22.614 1.846 557 23.22 1.192 94 23.08 0.728 16 
Mean corpuscular hemoglobin 
concentration 
g/L 340.397 18.244 567 341.00 10.327 94 336.81 11.397 16 
Red cell distribution width %CV 14.471 1.623 475 12.99 3.576 94 14.76 2.059 16 
HEMOSTASIS                     
Platelet count x 10⁹/L 322.683 121.355 341 312.93 108.046 92 302.06 51.177 16 
Mean platelet volume fl 8.980 1.653 332 8.13 0.933 86 8.99 1.829 16 
 
(a) Potential clinical significance was considered if the magnitude of the difference in the parameter 
comparison had practical relevance with respect to physiological or clinical state.        
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Table 2.5. Serum biochemistry values comparing healthy, captive (un-implanted), 
wild and captive-release Vancouver Island marmots (Marmota vancouverensis). 
Bold indicates comparisons with statistical and potential clinical significance (a).  
 
Parameter Units 
Captive     
Mean  
S.D. N 
Wild 
mean 
S.D. N 
Captive-
release 
mean 
S.D. N 
ELECTROLYTES AND ACID-
BASE 
                    
Sodium mmol/L 144.16 4.811 335 142.05 4.148 79 139.45 6.729 11 
Potassium mmol/L 5.241 2.771 334 7.26 3.043 79 9.98 5.900 11 
Sodium / Potassium ratio ratio 29.43 5.842 334 22.13 6.779 79 16.91 6.039 11 
Chloride mmol/L 101.32 6.094 332 103.10 4.205 79 99.27 4.650 11 
Bicarbonate mmol/L 26.29 6.624 96 25.93 4.131 15 27.44 2.297 9 
Carbon Dioxide mmol/L 26.66 5.979 211 24.33 5.673 64 28.50 3.536 2 
Anion Gap  21.39 7.333 318 21.65 7.968 79 22.55 4.712 11 
Calcium mmol/L 2.40 0.222 404 2.42 0.979 79 2.28 0.109 11 
Phosphorous mmol/L 1.70 0.427 405 2.14 0.740 79 1.82 0.526 11 
Calcium / Phosphorous ratio ratio 1.50 0.385 379 1.26 0.709 79 1.34 0.364 11 
Calculated Osmolality mmol/kg 298.73 7.913 317 297.20 6.464 79 294.36 5.801 11 
PROTEINS                     
Total Protein g/L 65.55 9.919 455 54.00 6.278 79 55.18 6.080 11 
Albumin g/L 29.09 4.833 369 25.68 7.185 79 23.45 3.078 11 
Globulin g/L 35.29 7.131 365 29.01 4.648 78 31.73 3.636 11 
Albumin / Globulin ratio ratio 0.90 0.619 366 0.88 0.139 79 0.75 0.082 11 
LIVER AND MUSCLE                     
Total Bilirubin μmol/L 2.81 1.848 263 3.16 1.718 64 4.56 1.236 9 
Alkaline Phosphatase IU/L 75.70 60.877 367 94.48 123.009 79 75.00 26.680 11 
Alanine Aminotransferase  IU/L 28.35 40.501 333 17.46 12.506 79 13.09 7.739 11 
Aspartate Aminotransferase IU/L 49.89 72.258 311 36.60 24.691 52 54.09 38.454 11 
Gamma Glutamyltransferase IU/L 4.77 6.046 333 4.66 3.293 76 3.36 2.420 11 
Creatinine Phosphokinase IU/L 649.92 987.135 398 813.01 1193.698 79 522.00 111.966 11 
 
(a) Potential clinical significance was considered if the magnitude of the difference in the parameter 
comparison had practical relevance with respect to physiological or clinical state.        
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Table 2.5. (cont.) Serum biochemistry values comparing healthy, captive (un-
implanted), wild and captive-release Vancouver Island marmots (Marmota 
vancouverensis). Bold indicates comparisons with statistical and potential clinical 
significance (a).  
 
Parameter Units 
Captive     
Mean  
S.D. N 
Wild 
mean 
S.D. N 
Captive-
release 
mean 
S.D. N 
Cholesterol  mmol/L 7.94 1.994 37 6.32 1.388 33 No data No data No data 
Glucose mmol/L 8.97 2.504 440 8.75 2.669 79 6.81 2.071 11 
RENAL FUNCTION                     
Blood Urea Nitrogen mmol/L 11.85 3.967 441 10.48 2.712 79 9.63 2.633 11 
Creatinine μmol/L 83.31 24.741 427 73.59 22.758 79 65.55 10.211 11 
Bun / Creatinine ratio ratio 0.16 0.086 427 0.16 0.067 79 0.151 0.052 11 
OTHER           
Lactose Dehydrogenase IU/L 1784.97 822.289 30 No data No data No data No data No data No data 
Amylase IU/L 1105.81 496.744 43 587.21 279.358 34 No data No data No data 
Lipase IU/L 181.11 134.140 38 204.91 145.485 33 No data No data No data 
Tetra Iodothyronine nmol/L 61.88 14.315 77 42.50 14.470 46 No data No data No data 
 
(a) Potential clinical significance was considered if the magnitude of the difference in the parameter 
comparison had practical relevance with respect to physiological or clinical state.        
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Table 2.6. Hematology values comparing (i) clinically normal, un-implanted, (ii) 
clinically normal, implanted, and (iii) clinically abnormal Vancouver Island 
Marmots (Marmota vancouverensis). Bold indicates comparisons with statistical 
and potential clinical significance (a).  
 
Parameter Units 
U
n
-i
m
p
la
n
te
d
 
m
e
an
 
S.D. N 
Im
p
la
n
te
d
 m
e
an
 
S.D. N 
N
o
n
-
re
p
re
se
n
ta
ti
ve
 
m
e
an
 
S.D. N 
WHITE BLOOD CELLS                     
White blood cells x 10⁹/L 5.081 2.447 857 5.213 1.970 174 6.468 3.718 65 
Segmented 
neutrophils 
x 10⁹/L 2.703 1.642 854 2.909 1.428 174 3.726 2.583 65 
Band neutrophils x 10⁹/L 0.003 0.027 854 0.000 0.000 174 0.000 0.000 65 
Lymphocytes x 10⁹/L 1.978 1.237 854 1.936 1.169 174 2.111 1.406 65 
Monocytes x 10⁹/L 0.346 0.373 854 0.311 0.283 174 0.505 0.673 65 
Eosinophils x 10⁹/L 0.035 0.075 854 0.035 0.062 174 0.037 0.069 65 
Basophils x 10⁹/L 0.015 0.035 854 0.019 0.036 174 0.041 0.152 65 
ERYTHROCYTES                     
Red blood cells x 10 ¹²/L 6.35 0.74 853 6.73 0.55 173 6.31 0.87 60 
Hemoglobin g/L 143.47 16.94 843 148.87 11.07 174 138.35 20.54 60 
Hematocrit L/L 0.42 0.05 857 0.44 0.03 174 0.41 0.06 64 
Mean corpuscular 
volume 
fl 66.13 4.39 819 65.73 2.76 174 64.62 4.30 60 
Mean corpuscular 
hemoglobin 
pg 22.49 1.68 813 22.17 1.11 174 21.95 1.45 60 
Mean corpuscular 
hemoglobin 
concentration 
g/L 340.06 16.18 823 337.01 9.87 174 340.05 14.49 60 
Red cell distribution 
width 
%CV 14.24 2.14 731 14.62 2.01 174 14.68 3.17 57 
HEMOSTASIS                     
Platelet count x 10⁹/L 314.15 106.686 595 354.08 92.153 174 394.21 172.393 43 
Mean platelet volume fl 8.92 1.500 570 8.94 1.204 174 8.61 1.500 40 
 
(a) Potential clinical significance was considered if the magnitude of the difference in the parameter 
comparison had practical relevance with respect to physiological or clinical state.        
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Table 2.7. Serum biochemistry values comparing clinically normal un-implanted 
and implanted and clinically abnormal Vancouver Island Marmots (Marmota 
vancouverensis). Bold indicates comparisons with statistical and potential clinical 
significance (a).  
 
Parameter Units 
U
n
-i
m
p
la
n
te
d
 
m
e
an
 
S.D. N 
Im
p
la
n
te
d
 m
e
an
 
S.D. N 
C
lin
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al
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n
o
rm
al
 m
e
an
 
S.D. N 
ELECTROLYTES AND 
ACID-BASE 
                    
Sodium mmol/L 143.79 4.69 461 143.35 4.31 72 144.19 3.82 54 
Potassium mmol/L 5.46 2.67 460 6.74 3.53 72 5.38 1.15 54 
Sodium / Potassium 
ratio 
ratio 28.38 6.08 460 24.77 7.86 72 27.78 5.86 52 
Chloride mmol/L 101.86 5.62 458 102.58 4.63 72 101.23 3.58 52 
Bicarbonate mmol/L 26.48 6.33 117 25.97 3.67 30 25.87 4.67 15 
Carbon Dioxide mmol/L 26.46 5.67 316 25.64 4.97 42 25.88 8.29 33 
Anion Gap  20.78 7.06 444 21.73 7.50 72 22.71 8.72 48 
Calcium mmol/L 2.44 0.92 530 2.48 0.72 72 2.48 0.18 56 
Phosphorous mmol/L 1.82 0.51 531 2.15 0.72 72 2.00 0.46 56 
Calcium / Phosphorous 
ratio 
ratio 1.49 1.38 505 1.26 0.60 72 1.29 0.42 54 
Calculated Osmolality mmol/kg 297.58 7.91 443 297.17 6.10 72 298.24 7.48 49 
PROTEINS                     
Total Protein g/L 62.89 10.47 581 56.72 5.53 72 60.59 7.92 58 
Albumin g/L 28.04 4.72 495 26.06 7.47 72 26.89 4.36 55 
Globulin g/L 33.50 7.22 491 31.47 4.22 71 33.42 6.96 55 
Albumin / Globulin ratio ratio 0.90 0.54 492 0.81 0.13 72 0.85 0.22 53 
LIVER AND MUSCLE                     
Total Bilirubin μmol/L 2.70 1.73 370 3.08 1.51 66 3.44 3.18 48 
Alkaline Phosphatase IU/L 75.14 55.83 493 90.07 125.44 72 62.24 38.63 54 
Alanine 
Aminotransferase  
IU/L 24.46 35.46 455 14.68 11.50 72 18.94 53.38 51 
Aspartate 
Aminotransferase 
IU/L 45.51 64.45 405 31.83 23.88 54 91.32 361.58 28 
 
(a) Potential clinical significance was considered if the magnitude of the difference in the parameter 
comparison had practical relevance with respect to physiological or clinical state.        
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Table 2.7. (cont.) Serum biochemistry values comparing clinically normal un-
implanted and implanted and clinically abnormal Vancouver Island Marmots 
(Marmota vancouverensis). Bold indicates comparisons with statistical and 
potential clinical significance (a). 
 
Parameter Units 
U
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p
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n
te
d
 
m
e
an
 
S.D. N 
Im
p
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n
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S.D. N 
C
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n
o
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e
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S.D. N 
ELECTROLYTES AND 
ACID-BASE 
                    
Gamma 
Glutamyltransferase 
IU/L 4.61 5.35 455 3.86 3.03 72 3.26 3.28 53 
Creatinine 
Phosphokinase 
IU/L 650.75 897.44 524 568.46 1103.35 72 610.11 525.89 54 
Cholesterol  mmol/L 7.23 2.02 68 7.38 1.24 4 7.91 2.88 11 
Glucose mmol/L 8.88 2.43 56 8.13 2.32 72 8.69 2.71 57 
RENAL FUNCTION                     
Blood Urea Nitrogen mmol/L 11.30 3.89 567 9.84 2.85 72 11.14 4.16 57 
Creatinine μmol/L 83.20 24.00 553 77.32 19.25 71 88.26 29.88 57 
Bun / Creatinine ratio ratio 0.15 0.08 553 0.13 0.05 71 0.14 0.06 56 
OTHER           
Lactose Dehydrogenase IU/L 1784.97 822.29 30 
No 
data 
No data 
No 
data 
2590.50 587.61 2 
Amylase IU/L 893.31 490.28 74 655.60 269.49 5 753.60 388.75 15 
Lipase IU/L 181.60 115.37 68 330.40 300.58 5 145.92 43.34 12 
Tetra Iodothyronine nmol/L 57.70 16.40 128 56.48 21.64 25 65.22 27.92 13 
 
(a) Potential clinical significance was considered if the magnitude of the difference in the parameter 
comparison had practical relevance with respect to physiological or clinical state. 
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Table 2.8. Summary of significance levels in hematology parameters between specific treatments or groups of Vancouver Island 
Marmots (Marmota vancouverensis). Grey indicates statistical significance at α < 0.01 and black indicates that there is both 
statistical significance at α < 0.01 and potential clinical significance (a). 
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Captive versus                   
Wild 
<0.01 0.90 0.23 <0.01 <0.01 0.08 0.14 0.48 0.55 1.00 <0.01 <0.01 0.76 <0.01 0.48 <0.01 
Captive versus             
Captive-
Release 
<0.01 0.81 0.62 <0.01 0.34 0.87 0.45 0.61 0.96 1.00 <0.01 0.31 0.43 0.49 0.50 0.98 
Wild versus                        
Captive-
Release 
0.34 0.77 1.00 0.03 0.08 0.44 0.21 0.81 0.72 1.00 0.35 0.69 0.14 0.06 0.69 0.01 
                 
Un-Implanted 
versus                  
Implanted 
0.50 0.12 0.14 0.68 0.24 1.00 0.17 <0.01 <0.01 <0.01 0.25 0.02 0.02 0.03 <0.01 0.87 
Un-implanted 
versus            
Non-
representative 
<0.01 <0.01 0.37 0.41 <0.01 0.84 <0.01 0.69 0.03 0.15 0.01 0.02 1.00 0.15 <0.01 0.21 
 
(a) Potential clinical significance was considered if the magnitude of the difference in the parameter comparison had practical relevance with respect 
to physiological or clinical state. 
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Table 2.9. Summary of significance levels in serum biochemistry parameters between specific treatments or groups of Vancouver 
Island Marmots (Marmota vancouverensis). Grey indicates statistical significance at α < 0.01 and black indicates that there is 
both statistical significance at α < 0.01 and potential clinical significance (a). 
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Captive versus                   
Wild 
<0.01 <0.01 <0.01 0.01 <0.01 0.78 0.71 <0.01 <0.01 0.11 <0.01 <0.01 <0.01 0.78 0.17 0.05 
Captive versus             
Captive-
Release 
<0.01 <0.01 <0.01 0.27 0.67 0.60 0.07 0.36 0.17 0.07 <0.01 <0.01 0.10 0.42 0.01 0.97 
Wild versus                        
Captive-
Release 
0.08 0.02 0.02 <0.01 0.31 0.71 0.64 0.17 0.72 0.17 0.56 0.31 0.06 <0.00 0.02 0.60 
                 
Un-implanted 
versus                  
Implanted 
0.45 <0.01 0.82 0.96 0.96 0.96 0.99 0.82 0.95 0.98 0.84 0.79 0.92 0.95 0.93 0.92 
Un-implanted 
versus            
Non-
representative 
0.55 0.83 0.97 0.97 0.97 0.93 0.99 0.85 0.96 0.98 0.94 0.94 1.00 0.98 0.88 0.94 
 
 
(a) Potential clinical significance was considered if the magnitude of the difference in the parameter comparison had practical relevance with respect 
to physiological or clinical state. 
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Table 2.9. (continued) Summary of significance levels in serum biochemistry parameters between specific treatments or groups 
of Vancouver Island Marmots (Marmota vancouverensis). Grey indicates statistical significance at α < 0.01 and black indicates 
that there is both statistical significance at α < 0.01 and potential clinical significance (a). 
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Captive versus                   
Wild 
0.02 0.19 0.88 0.20 <0.01 0.48 <0.01 <0.01 1.00 
No 
data 
<0.01 0.48 <0.01 
Captive versus             
Captive-Release 
0.21 0.85 0.44 0.67 
No 
data 
<0.00 0.07 0.02 0.73 
No 
data 
No 
data 
No 
data 
No 
data 
Wild versus                        
Captive-Release 
0.26 0.06 0.21 0.42 
No 
data 
0.02 0.33 0.25 0.64 
No 
data 
No 
data 
No 
data 
No 
data 
              
Un-implanted 
versus                  
Implanted 
0.91 0.94 0.96 0.97 0.99 0.83 0.89 0.93 0.93 
No 
data 
0.90 0.73 0.97 
Un-implanted 
versus            
Non-
representative 
0.96 0.86 0.93 0.99 0.90 0.96 0.99 0.95 0.97 0.81 0.90 0.90 0.87 
 
(a) Potential clinical significance was considered if the magnitude of the difference in the parameter comparison had practical relevance with 
respect to physiological or clinical state. 
 
5
5 
56 
 
 
DISCUSSION 
In this project, reference intervals for 16 hematology and 30 serum 
biochemistry parameters were calculated from laboratory data derived from 
clinically healthy Vancouver Island Marmots over a 23-year period. In addition to 
providing baseline health data, these parameters were qualitatively compared to 
values that have been generated from other rodent species. The general 
characteristics of the VIM reference ranges appeared to be commensurate with 
values for other small to medium sized rodents. 
The hematology and serum biochemistry parameters also were used as a 
measure of comparison between different management VIM conditions (wild, 
captive and captive-release, un-implanted and implanted, clinically normal and 
abnormal). Eleven of the 46 parameters showed no clinical or statistical differences 
between any of the groups that were compared, including values which were 
derived from clinically abnormal animals. Twenty-eight of the 46 parameters 
showed evidence of statistically significant differences between certain groups, but 
the small magnitude and nature of these differences did not suggest physiological or 
clinical significance.  
Eight of the 46 parameters had biologically plausible and statistically 
significant differences between a portion of the compared groups. This included 5 
leukogram parameters; white blood cells, segmented neutrophils, lymphocytes, 
monocytes, basophils, and 3 serum biochemistry parameters; total protein, albumin, 
and globulin. Potentially significant differences in leukogram and protein 
parameters occurred between the captive and free-ranging groups (both wild and 
captive-release). Also, leukogram parameters of clinically normal, un-implanted 
marmots were lower than the clinically-abnormal group. Although the blood 
samples from the clinically abnormal animals were collected under a range of 
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different scenarios, at least 9 were obtained from marmots with confirmed infections 
and elevated white blood cells and neutrophils.  In addition to indicating 
inflammation or infection, white blood cells (including neutrophils, lymphocytes, 
monocytes, and basophils) and serum proteins also are indicators of general stress 
and immune status (Mellish et al. 2010; Barker & Boonstra, 2005). Although group 
characteristics for leukograms and serum proteins still fell within the established 
references ranges and the magnitude of differences between the groups were 
relatively small, these results suggest that leukogram and protein values may have 
the potential to differentiate the physiological or immunological status of healthy 
individuals in the different management groups.         
Although hematology and serum biochemistry parameters are commonly 
advocated as a tool for the evaluation and comparison of health in individuals and 
populations (Ruykys et al., 2012; Mellish et al., 2010; Masello & Quillfeldt, 2004), 
there are many factors in addition to health status which may have the potential to 
influence blood values and reference ranges. This includes intrinsic factors such as 
age, sex, and seasonality (Stannard et al., 2013; Barker & Boonstra, 2005) and 
extrinsic factors such as sample collection, storage and transport, and laboratory 
methods of analysis (Dimauro, et al., 2008; Low et al., 2006). The challenge of using 
this type of data is determining which parameters are restricted to the evaluation of 
individuals, which vary according to factors like age and sex, which vary due to 
vagaries associated with sample handling and laboratory analysis, and which 
represent legitimate differences between individuals or groups under different 
treatments. Although statistically significant differences often may be identified, it is 
also important to consider the magnitude of these differences and their clinical, 
physiological, or biological relevance or implications (Nakagawa & Cuthill, 2007).     
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 In several instances, differences between groups could possibly be 
attributable to extrinsic factors. Analytical methodologies may have varied between 
laboratories (Low et al., 2006) and techniques may have altered over time. Due to the 
cost of analyses, it is also possible that institutions were somewhat selective in terms 
of which individuals they sampled, focusing on genetically important or older 
individuals. Pre-analytical factors, such as sample collection, handling and storage, 
may account for higher variation in results than analytical techniques (Maceda-
Veiga, et al., 2015). Although attempts were made to standardize the conditions 
under which blood was collected, stored, and transported, it is possible that some of 
the samples obtained from free-ranging marmots were artifactually compromised 
(Low et al. 2006). The measurement of lactose dehydrogenase, sodium, potassium, 
chloride, phosphorous, blood urea nitrogen, creatinine and glucose have all been 
shown to be influenced by temperature and storage interval (Monden et al. 2008; 
Reese et al. 2006). Under field conditions, some marmot samples may have been 
exposed to logistically imposed variations in ambient temperature and transport 
delays prior to laboratory analysis. This might represent a consideration in 
interpreting comparisons between free-ranging and captive marmots.  
It is important for ongoing species recovery and future decision-making to 
better understand if perturbations or artificial manipulation, including captive 
management and implant surgeries, are having an observable impact on the health 
of the species. In this project (i) the reference values for clinically healthy Vancouver 
Island Marmots are comparable to those of other related mammal species, (ii) the 
parameters of marmots released from captivity are comparable to their wild 
counterparts, (iii) the parameters of marmots that have been surgically implanted 
with abdominal radio-transmitters do not differ in any clinically significant way 
from healthy marmots without transmitters, (iv) healthy captive marmots 
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demonstrate higher, statistically significant leukogram and serum protein 
parameters, compared to healthy free-ranging individuals, which is possibly 
suggestive of increased chronic stress or subclinical health influences (Mellish et al. 
2010; Barker & Boonstra, 2005), and finally, (v) white blood cell and protein metrics, 
in conjunction with other clinical data, may present a simple, efficient, and cost-
effective parameter for monitoring differences between management groups.   
  Hematology and serum biochemistry have great utility for assessing health 
and identifying disease in individuals. Recognising abnormality or dysfunction in 
these parameters requires an appreciation of normal and this is facilitated by the 
establishment of baseline measurements. Although the utility of these 
measurements for assessing group or population effects are not as straightforward, 
monitoring these parameters over time may allow for the identification of increased 
individual dysfunction, for ongoing comparisons between the different management 
groups, and for continued surveillance of the marmots’ overall health status. 
Recognition of future alterations in hematology or serum biochemestry 
characteristics, in concert with other clinical data, may help to signal changes in 
health. This in turn may serve to identify emerging health risks that could influence 
the species’ overall health and recovery.  
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CHAPTER 3 
SURVEILLANCE OF VANCOUVER ISLAND MARMOT (MARMOTA VANCOUVERENSIS) 
HEALTH USING CLINICAL AND POST MORTEM EXAMINATIONS, AND FIELD MORTALITY 
DETERMINATION  
 
INTRODUCTION 
Guidelines produced by the International Union for Conservation of Nature 
(IUCN) on the management of ex-situ populations, reintroductions, and other 
conservation translocations, have identified health and disease monitoring as an 
essential component in an effective conservation program (IUCN, 2013; IUCN, 2002). 
Monitoring helps to identify ongoing or novell threats and allows for the adaptation 
of management, release, and surveillence regimes. The establishment of 
characteristic health parameters in captive, captive-release and wild populations 
delineates what is normal or expected under each treatment and how these differ 
between groups (Deem et al. 2001). Differences in parameters may reflect a response 
to disparate conditions or they may signal a potential health challenge associated 
with management or emerging stressors.  
Despite their widely acknowledged potential to influence success in 
conservation programs, the effects of animal health and disease are infrequently 
reported (Mathews et al. 2005). Monitoring health and disease in ex situ and in situ 
populations presents a significant challenge. Determining the spectrum of influence 
that captive conditions have on the health of an endangered species is time-
consuming and complicated and monitoring free-ranging populations is limited by 
the challenges associated with observing, examining, sampling and tracking 
individuals under field conditions. The health data obtained from these respective 
populations often is of disparate quality and this makes comparisons problematic. 
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Identifying potential health threats requires the organization and collation of 
data from a variety of sources. Grouping or clustering health data may have the 
potential to facilitate comparisons and allow timely detection of potential trends. 
Syndromic surveillance involves the systematic collection and evaluation of a wide 
range of health data from multiple sources to identify, characterize, and predict 
potential patterns, clusters, or syndromes as they are occurring. This allows for the 
detection of non-specific trends and for the tracking of specific syndromes using 
incomplete or imperfect data. This type of surveillance facilitates the filtering and 
efficient transfer of health or disease information so that risks can be identified and 
further investigated, and so that timely, informed decisions can be made. Although 
syndromic surveillance has been most commonly used to filter and identify 
syndromes in large, complex datasets, it may also present a conceptual framework 
for the detection of health and disease patterns in ex situ and in situ populations of 
endangered species, which may only be signaled by incomplete data from a 
relatively small number of individuals or events. This allows for the timely 
detection, comparison, investigation, and management of health risks before 
definitive diagnoses can be fully realized.  
The Vancouver Island Marmot (Marmota vancouverensis) is a critically 
endangered sciurid endemic to the mountains of central Vancouver Island (Swarth, 
1912; Swarth, 1911).  In the early to mid-1980s there were indications that the 
marmot’s population was stable or increasing, with approximately 300 to 350 
individuals occupying at least 30 colony sites. However, in the late 1980s and 
throughout the 1990s, the Vancouver Island Marmot (VIM) demonstrated 
precipitous declines. By 1998 the wild population had dropped below 100 animals 
and by 2003 it was reduced to less than 30 individuals at 5 colonies, making it 
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Canada’s most endangered mammal (Jackson et al. 2015; Nagorsen, 2005; Janz et al. 
2000).  
The impending threat of species extinction led to the initiation of an intensive 
captive breeding program in 1997. Since its inception, this program has involved the 
participation of three Canadian zoological institutions, the Toronto Zoo (TZ), the 
Calgary Zoo (CZ), and the Mountain View Conservation and Breeding Society in 
Langley, British Columbia (MV) and the construction of a dedicated marmot facility 
at Mount Washington on Vancouver Island, the Tony Barrett Mount Washington 
Marmot Recovery Centre (MRC). Although there has been significant recovery of 
the wild population, the VIM continues to be managed by an intensive program of 
captive breeding, reintroduction, and translocations. Further details on the history of 
the VIM recovery project are provided in Chapter 1.  
In situ and ex situ management has subjected the VIM to a unique and 
dynamic assemblage of natural and artificial influences. The ability to identify and 
track these influences with respect to marmot health is vital for effective long-term 
management and for vigilent recognition, ellucidation, and mitigation of potential 
risks that may jeoprodise the recovery of this species. The marmot recovery project 
has generated a great range of qualitative and quantitative, health-related data from 
both free-ranging and captive marmots. These have originated from a multitude of 
sources, and include clinical, pathological, morphological, physiological, 
demographic, epidemiological, and environmental data. Because of its disparate, 
individualistic, and heterogeneous nature, the utility of these data for elucidating 
marmot health patterns has not been fully realized.  
Clinical evaluations conducted by veterinarians, necropsies performed by 
veterinary pathologists, and properly vetted observations made by field staff 
monitoring free-ranging marmots through radio-telemetry, have the potential to 
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offer reliable and robust health-related data. Although this information has been 
typically used to evaluate individuals or singular events, it also has the potential to 
be extrapolated more broadly. In this chapter I use syndromic surveillence of 
disparate, historical data from physical examinations, post mortem examinations, 
and field evaluation of marmot mortalities, to identify possible trends and risk 
factors relating to the health of captive, captive-release and wild populations of VIM, 
and to evaluate the utility of this approach in informing future marmot health 
management and species recovery.  
 
MATERIALS AND METHODS 
Classification of marmot management groups  
Captive marmots were defined as any captive-born marmot originating from the TZ 
(Toronto, Ontario), the CZ’s Devonian Wildlife Conservation Centre (De Winton, 
Alberta), the MV (Langley, British Columbia) and the MRC (Mount Washington, 
British Columbia) or any wild-born marmot that was maintained at one of these 
facilities for more than a single, active season for the purpose of captive breeding. 
Four wild-born marmots that died during their initial 30-day quarantine period 
following capture were intended to be part of the captive breeding program and 
were defined as captive marmots even though they were not maintained beyond 
one active season. Wild-born marmots that were held for brief intervals at the MRC 
(periods of time that ranged from hours to weeks), and then re-released during the 
same active season, were classified as wild. These individuals were captured and 
held to simplify translocations and were never intended to be part of the captive 
breeding program. This latter group did not suffer any mortalities during their 
limited time in captivity.    
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From 1997 to 2016, a total of 639 individuals were maintained in captivity, 
including 61 wild-born marmots originally captured from the wild and 578 marmots 
(from 170 litters) born and weaned in captivity. This number does not include 
marmots from at least 11 unsuccessful, captive litters (6.1% of total litters) in which 
all pups failed to survive to weaning age (at approximately 28 to 30 days) or 
individual pups that were part of successfully weaned captive litters that failed to 
survive to weaning age.  
Captive-release marmots were defined as those animals released to the wild from 
captivity, including those originally born in captivity and any wild-born marmot 
that had been maintained in captivity for more than a single active season prior to 
release. From 2003 to 2016 a total of 490 captive marmots were released to the wild 
including 482 captive-born individuals (103 born and weaned at TZ, 116 at CZ, 98 at 
MV and 165 at MRC) and 8 wild-born individuals (time in captivity ranged from 394 
to 4350 days, average = 2091 days). Two of these wild-born, captive-release marmots 
were recaptured and permanently returned to captivity.   
All 490 captive marmots that were released to the wild were maintained at 
the MRC for a minimum of 30 days prior to release, as a way of verifying their 
health and minimizing the potential for introduction of novel pathogens into the 
extant free-ranging populations. From 2003 to 2012, all 373 of the captive non-pups 
released to the wild spent at least one hibernation at the MRC. The average interval 
that these marmots spent at the MRC prior to release was 450 days (range 207 to 
2271 days). From 2008 to 2011, 35 pups born at the MRC were released to the wild in 
their first summer (average age 112 days, range 93 to 123 days). From 2013 to 2016 a 
total of 82 captive marmots, originating from the other captive facilities, were 
released to the wild during the same year in which they arrived at the MRC. The 
average interval of time that these marmots spent at the MRC prior to release, was 
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58 days (range 42 to 77 days). Overall, 50.3% of the releases from captivity occurred 
in July, 27.8% in August, 14.0% in September, 7.4% in June, 0.4% in May, and 0.2% in 
April.    
Pre-conditioned marmots were defined as captive-release individuals that were 
translocated to a new site after successfully surviving at least one hibernation in the 
wild. This treatment primarily represented an attempt to mitigate the poor survival 
of captive-release marmots introduced directly into Strathcona Park. Captive 
marmots were released at Mount Washington, where survival was consistently high, 
and then subsequently recaptured and moved after at least one winter in the wild. In 
2008 one captive-release individual was opportunistically relocated to Mount Cain 
after successfully surviving its first wild hibernation at Mount Washington and from 
2012 to 2016, a total of 32 pre-conditioned marmots were trapped and translocated 
from Mount Washington to Strathcona Park. The interval between initial release 
from captivity and subsequent relocation ranged from 316 to 1042 days (average = 
402 days).  Between 2003 and 2009, four captive-release marmots that had moved 
into unsuitable habitat shortly after their initial release were recaptured and 
returned to their original release site or to a new site and were not considered to be 
pre-conditioned. 
Wild marmots were defined as any wild-born individual that had never been 
maintained in a captive facility or any wild-born marmot temporarily held at the 
MRC for less than a single, active season and then returned to the wild.  
Translocation marmots were wild marmots that were deliberately moved from one 
site to another. From 1996 to 2015, fourteen wild marmots were translocated to 
various sites in the Nanaimo Lakes region. From 2012 to 2016 a total of 58 wild 
marmots were translocated from Mount Washington to Strathcona Park.  
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Captive-release, pre-conditioned, wild, and translocation marmots were 
collectively defined as ‘free-ranging’.   
Marmot ages were categorized as young-of-the-year (pups or juveniles in 
their first summer), yearling (individuals in their second summer), two-year old 
(third summer), and adults (fourth or subsequent summers). The age of all captive-
born individuals was known with certainty. The age categories of wild-born 
marmots were known or extrapolated from previously described pelage 
characteristics (Bryant 1998) and relative size and appearance. In the field, age 
categories could be determined with relative certainty, except in the case of some 
individuals classified as two year-olds, that exhibited variable characteristics which 
overlapped those of yearlings and adults.  
Monitoring of free-ranging marmots 
Free-ranging marmots were monitored in the field with surgically implanted, 
intra-abdominal VHF (very high frequency) radio-transmitters. Internal transmitters 
were used because the dramatic seasonal mass changes that individuals demonstrate 
during hibernation made conventional neck collars impractical. From 1992 to 2016 a 
total of 898 implant surgeries were performed on VIM including 96 replacement 
surgeries. Techniques for surgical implantation of intraperitoneal transmitters have 
been previously described in a range of wild species (Van Vuren, 1989; Ranheim et 
al. 2004; Soto-Azat et al. 2008) and the specific details concerning transmitters and 
handling, anesthetic and surgery techniques used on this project are described in 
more detail in Appendix D, E and F. Because implantation required a surgical 
procedure and an adequate capacity for convalescence, marmots were not implanted 
close to hibernation (i.e. early in the field season following emergence, when body 
condition and food resources were low and when female marmots might be 
pregnant or late in the field season close to immergence when the marmots’ 
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metabolic rate was starting to decline and healing capacity might be reduced). Most 
surgeries were performed between the middle of June and the end of August. 
During the course of this project, temperature-responsive transmitters from Custom 
Telemetry ® (Watkinsville, Georgia), Telonics ® (Mesa, Arizona), Advanced 
Telemetry Systems ® (Isanti, Minnesota) and Holohil Systems Limited ® (Carp, 
Ontario) were used. The pulse rate and temperature response of the transmitters 
was configured to maximize functionality and prolong battery life. A reduced pulse 
rate associated with lowered body temperature helped to prolong battery life during 
hibernation and during the active season a low transmitter pulse rate was used to 
signal potential marmot mortalities.  
Four hundred and eighty-four of the 490 captive-release marmots were 
surgically implanted with an abdominal radio transmitter prior to release and then 
afforded a period of convalescence in captivity. Intervals between captive surgery 
and release ranged from 11 to 93 days (average = 28 days). Three implanted 
marmots were held until the following year due to transient problems or injuries 
that precluded same-year release and one individual died prior to release due to 
transmitter complications. One marmot was recaptured and surgically implanted 50 
days after being initially released without a transmitter and 32 individuals were 
later recaptured and had their transmitters replaced. One captive-release marmot 
was recaptured for a second transmitter replacement.  
From 1992 to 2016 a total of 379 implant surgeries were performed on wild 
marmots including 63 replacement surgeries. Wild marmots being intentionally 
prepared for translocation were surgically implanted with radio-transmitters and 
then allowed to convalesce at their familiar colony sites for a period which ranged 
from 21 to 37 days (average = 30 days). In five instances, wild marmots were not 
recaptured and translocated until the year following their surgery. Four marmots 
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that were captured at aberrant locations including Bamfield, Nanaimo (2), and 
Nanoose on Vancouver Island were surgically implanted and translocated to 
suitable habitat within days of initial capture. All four marmots survived for at least 
350 days (range 350 to 1511 days), indicating that these marmots were not adversely 
affected by prompt relocation following surgery.         
Physical Examinations 
Comprehensive physical examinations were conducted on both captive and 
free-ranging VIM. These examinations were conducted by a veterinarian and 
involved an evaluation of the cardiovascular, respiratory, musculoskeletal, nervous, 
integumentary, and urogenital systems, and an assessment of the marmot’s body 
condition and weight. Individuals with previously implanted radio-transmitters 
were routinely palpated to ensure that the units were mobile or free-floating within 
the abdominal cavity. Marmots that did not display identifiable physical 
abnormalities were classified as clinically normal or healthy at the time of 
examination. Prior to physical examination, most marmots were immobilized with 
an intramuscular injection of ketamine hydrochloride (10 mg/kg) and midazolam 
hydrochloride (0.25 mg/kg), and then maintained on inhaled isoflurane. In some 
instances, marmots were mask induced with isoflurane without receiving any 
injectable immobilization agents. 
Physical examinations of VIM were conducted under the following 
conditions:  
1) Captive marmots:  
i) In addition to examinations initiated during quarantine (total = 55) or in 
response to specific health concerns (61), all captive marmots maintained 
at the TZ, CZ, MV and MRC received routine physical examinations on an 
annual or biennial basis. These examinations were conducted late in the 
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active season in anticipation of hibernation or prior to transfer to another 
captive facility.      
ii) Captive-release, pre-release - 485 of the 490 marmots released from 
captivity were surgically implanted with radio-transmitters and were 
given pre-operative examinations at MRC to confirm their suitability for 
surgery. There was also a pre-release examination which followed the 
post-operative, convalescence period. This second examination occurred 
on the day of release or on the day that preceded it. The 5 un-implanted 
marmots also received pre-release exams.   
2) Free-ranging marmots: 
i) Captive-release, post-release - marmots were examined if they were 
recaptured for transmitter replacement surgery.   
ii) Captive-release, pre-conditioned - following recapture, these marmots 
were typically held for a short interval (hours to weeks) at the MRC and 
then examined on the day of their re-release to a new site or on the day 
that preceded it. 
iii) Wild marmots receiving transmitters were given pre-operative 
examinations to confirm their suitability for surgery.  
iv) Wild marmots also received examinations if they were re-trapped for 
transmitter replacement surgery.   
v) Thirty-eight out of 61 wild marmots were examined shortly after capture 
but prior to being transferred to the captive breeding program.    
vi) Wild marmots, translocation - these marmots were recaptured after an in 
situ convalescent period and typically held for a short interval (hours to 
days) at the MRC. These marmots were re-examined on the day of their 
translocation or on the day that preceded it. 
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Post Mortem Examination / Causes of mortality 
All marmots found dead in the wild or in captivity underwent a standardized 
post mortem examination. Necropsies were performed by pathologists at the 
Province of British Columbia’s Animal Health Centre (Abbotsford, BC), the Province 
of British Columbia’s Wildlife Branch (Victoria, British Columbia), the Calgary Zoo 
(Calgary, Alberta) and the Ontario Veterinary College (University of Guelph, 
Guelph, Ontario). Wherever possible, the same pathologists were recruited to 
perform or review post mortem examinations, so that these individuals developed 
increased experience in recognizing, comparing and interpreting lesions and 
abnormalities, and were better able to identify potential patterns. The attending 
pathologist had the discretion to determine the thoroughness of the post mortem 
examination and to perform ancillary diagnostic procedures, as they felt necessary.  
The thoroughness of a post mortem examination also was determined by the 
circumstances under which a marmot was recovered. Captive VIM that died or were 
euthanized during the active season were examined within hours or days of death. 
This facilitated gross, histological and microbiological examination. Captive 
marmots that died during the hibernation period were most commonly recovered 
during routine nest-box checks, conducted at weekly to monthly intervals, and their 
carcasses demonstrated varying degrees of autolysis. Deterioration of the carcass 
was somewhat delayed by the cooler ambient temperatures (5 to 7° C) that 
characterized hibernation management. Typically, the tissues of these marmots 
maintained sufficient integrity for a macroscopic post mortem examination, but the 
potential for histological and microbiological examination was greatly reduced.   
Free-ranging VIM could not be monitored with the same day-to-day intensity 
as their captive counterparts, and this complicated the field recovery of intact, dead 
marmots. Although field workers occasionally encountered the remains of 
75 
 
 
unidentified marmots of unknown origin, most of the documented mortalities in 
free-ranging marmots involved individuals that were previously implanted with 
radio-transmitters and located by telemetry. Hibernation mortalities were identified 
in those marmots that failed to emerge from their burrow in the spring and whose 
transmitter remained underground on a slow pulse rate. If there were no indications 
as to cause of death following site investigation or if a slow transmitter pulse was 
detected remotely by aerial or ground telemetry, the cause of death was listed as 
“unknown”.  
The interval between death and recovery of free-ranging marmot remains 
was quite variable and ranged from days to years. The recovery of free-ranging 
marmots which had died during hibernation occurred on only two occasions and 
necessitated digging the dead marmots out of their hibernaculum. Decomposition of 
these recovered carcasses was probably delayed by the cooler and more stable, 
ambient temperatures that characterize natural burrows.    
The integrity of remains from dead, free-ranging marmots also could be 
influenced by consumption and disruption by predators or scavengers, moisture 
(rain or snow), sunlight and ambient temperatures. In most instances, the death of a 
free-ranging marmot resulted in the recovery of incomplete remains, which ranged 
from an isolated transmitter to a partial body. In the absence of a complete carcass, 
the proximate causes of a marmot mortality were determined by site investigation 
and the characteristics of the marmot remains.  
Classification of predator mortalities 
VIM are susceptible to a suite of predators (cougars, wolves, eagles, and 
bears), and each species typically left a characteristic presentation of the remains 
following a predation event.          
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Cougars (Puma concolor) are solitary hunters. Once a cougar successfully 
killed a non-juvenile marmot, it typically delayed feeding and relocated the carcass 
to a sheltered spot under the cover of dense vegetation (Naughton, 2012). Often 
these sites were situated well away from locations typically frequented by marmots. 
Cougars fastidiously prepared the marmot’s body prior to consumption. They used 
their incisors to barber or pluck the marmot’s fur, leaving an encircling perimeter or 
matt of hair. They typically removed and rejected the stomach and gastrointestinal 
tract of their prey (Wild, 2013) and where applicable, the implanted abdominal 
transmitter. Cougars also disarticulated the carcass during feeding and in many 
instances, they left the more robust bones (skull, pelvis, and long bones) and the 
poorly fleshed portions of the body (feet and tail).  
Grey Wolves (Canis lupus) are pack hunters and display competitive behavior 
following a predation event. They typically consumed marmots at the location of the 
kill, and ingested most of the carcass, including the bones, gastrointestinal tract, and 
skin. They would only leave small remnants such as the upper incisors mounted in a 
portion of the premaxillary bone, and a portion of the distal tail. Wolves would not 
consume abdominal transmitters, but they would frequently leave bite marks on the 
surface of units, particularly those that were encapsulated with wax. In addition, 
wolves often showed what appeared to be a gastro-colic response, and tell-tale feces 
often were found in close proximity to their marmot kills.     
The preferred prey size for Golden Eagles (Aquila chrysaetos) is 0.5 to 4.0 
kilograms (Watson, 1997) and most free-ranging VIM fall within this range. In many 
instances, Golden Eagle predation on full-size marmots left indications of an initial 
struggle, characterized by disturbance of low-lying vegetation, and feather and body 
tracks on the ground or in the snow. The eagle’s presence often was evidenced by 
down and contour feathers, and by large splashes of urates. A female Golden Eagle 
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has difficulty flying with a prey item that matches her own body weight 
(approximately 6.0 kilograms), and under most conditions, she can only manage to 
carry about half of this amount (Watson, 1997). Therefore, Golden Eagles often 
began consuming marmots at the kill site, leaving partial remains, including the 
skeleton and some viscera, surrounded by irregular patches of plucked hair. In a few 
instances, field workers flushed Golden Eagles off their marmot kills. On three 
occasions Golden Eagles were observed carrying small marmots (pups or yearlings) 
away from colony sites (Bryant, 1998) and at least one marmot radio-transmitter was 
used to locate a Golden Eagle nest (J. MacDermott, personal communication).  
Black Bears (Ursus americanus) were random, opportunistic predators of 
marmots and this was reflected in the apparently haphazard nature of carcass 
consumption. Bears would typically consume most of the bones and soft tissues and 
leave behind a twisted hide with irregular remnants of the subcutaneous fat and 
panniculus muscles, which was coated with detritus such as leaves, dirt, and broken 
twigs. In cases of bear predation there was also proximal evidence of the bear’s 
presence, such as piles of feces or a bedding area.  
Because of their small size, most marmot pups were probably carried away or 
consumed in their entirety after being killed. Implanted pups left negligible remains 
except for occasional clumps of hair, skin, and their transmitter.  
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RESULTS 
Physical Examination 
From August 1992 to September 2016, a total of 3,174 veterinary examinations 
were conducted on captive and free-ranging VIM. This includes examination of 632 
captive individuals and 353 wild individuals. Accounting for marmots that 
overlapped the two populations, a total of 944 individual marmots were examined. 
The circumstances of these examinations are summarized in Table 3.1 and the ages 
of wild and captive marmots are compared in Figure 3.1.    
On average, captive marmots were examined more frequently than wild 
marmots (an average of 4.1 examinations per captive marmot compared to 1.4 
examinations per wild marmot). Physical evaluation of captive marmots resulted in 
the identification of a number of health events or clusters that were not seen in free-
ranging marmots (Table 3.2). Although seven weaned pups died before receiving 
physical examinations, all of the remaining 571 captive-born pups were evaluated 
prior to their first hibernation. This compares to 63 wild pups who were either 
examined before being transferred into captivity (27) or prior to implant surgery 
(36). Captive-born pups exhibited a number of congenital disorders that were not 
identified in wild pups including a patent foramen ovale, bilateral cataracts, dental 
malocclusion, and bilateral aplasia of the hind feet. One wild-born pup that was 
brought into captivity possessed an atrial septal defect and his full sibling (born after 
the wild-born parents had been taken into captivity) exhibited stunting, micro-
opthalmia, and scoliosis. The greater longevity of captive marmots allowed for 
observation and physical examination of many older marmots, compared to their 
wild counterparts (Figure 3.1) and this may have allowed for the identification of 
additional age-related health events or syndromes within the captive population. 
Although cardiovascular disease and neoplasia often were diagnosed at the time of 
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necropsy following acute death in captive marmots, some of these cases were 
preceeded by observable clinical signs. Marmots with chronic heart disease 
exhibited murmurs or weight loss that were detected clinically and initial signs of 
neoplasia included emaciation, depression, inappetance, facial assymetry, epistaxis, 
and unilateral exopthlamos. Two mature, captive males exhibited acute hind end 
paralysis that resulted from degeneration and prolapse of their invertebral discs. 
Cardiovascular disease, neoplasia and disc degeneration were not identified in any 
of the free-ranging marmots that were given physical examinations.   
One condition that was exclusive to wild-born marmots was a syndrome of 
chronic, generalized, perifollicular dermatitis that was widespread in the original, 
extant colony at Mount Washington and was attributed to an unclassified, 
intrafollicular mite (Janz et al., 2000). This condition persisted in those individuals that 
were taken into the captive program, but it did not visibly affect their progeny or cage-
mates. 
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Table 3.1. Circumstances of 3,174 physical examinations conducted on captive and free-ranging Vancouver Island 
Marmots (Marmota vancouverensis). 
 
 
Captive                                                          
(2622) 
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1513 486 507 116 1 33 33 316 63 61 38 6 
 
a) Examination prior to surgical implantation of abdominal radio-transmitter 
b) Some marmots had more than one pre-release exam due to delays in their release or concerns about transient injuries. 
One implanted marmot died prior to release due to complications associated with its transmitter 
c) Examinations of wild-born marmots conducted in the initial captive quarantine period or exams initiated in response 
to specific health concerns 
d) One individual was surgically implanted 50 days after being released from captivity without a transmitter 
e) Physical examinations conducted on captured wild-born marmots prior to being placed in the captive program 
f) Miscellaneous examinations associated with ear-tag replacement or misidentified marmots that already had pre-existing 
transmitters   
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Figure 3.1. Age comparison of 3,107 physical examinations conducted on wild and captive Vancouver Island Marmots 
(Marmota vancouverensis).  
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Post Mortem Examination / Causes of Mortality 
Mortality in Captive Marmots: As of January 2017, 109 marmot deaths had occurred 
in captivity (49 wild-born and 60 captive-born). A post mortem examination was 
performed on 106 or 97.22% of the 109 captive mortalities. Examinations were not 
performed on two recently weaned pups whose bodies were not recovered. The 
body of a third pup that died from known conspecific trauma, was too badly 
mutilated for a necropsy. In one adult post mortem, advanced autolysis of the 
carcass (recovered during hibernation) precluded a diagnosis. A specific cause of 
death was identified in 106 of the mortalities, and the diagnostic categories are 
summarized in table 3.1. The sex-age distribution of the mortalities is summarized in 
figure 3.2. The average male age was 6.37 years (range 0.1 to 11.5) and the average 
female age was 8.17 years (range 0.1 to 14.6). Of the 78 marmots that survived to 
adulthood at 3 years of age, the average age for males was 8.9 years (n = 46) and the 
average age for females was 10.4 years (n = 32).   
Cardiovascular disease accounted for the highest number of captive marmot 
mortalities, and included 16 cases of dilatative or dilated cardiomyopathy, 6 cases of 
myocarditis, 1 case of endocardiosis, 1 case of cerebral hemorrhage, 1 case of 
atherosclerosis, 4 cases in which the pathologist diagnosed non-specific heart 
disease, and 3 cases which were described as congestive heart failure. One five-year 
old, captive-born male suffered cardiac arrest during anesthesia and a captive-born 
male died acutely of myocardial fibrosis at 1.4 years of age. Including two additional 
congenital cases (atrial septal defect, patent foramen ovale), 27 captive males died 
from cardiovascular disease compared to 9 females. Twenty-four males died of 
acquired cardiovascular disease in adulthood and their average age was 9.5 years 
(range 5 to 11.5). In the 9 females, the average age was 11.8 years (range 10.3 to 13.1).  
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Neoplasia occurred in combination with 5 of the 34 cardiovascular cases (3 
males, 2 females) and was identified in 21 additional mortalities (8 males, 13 
females). The anatomical categorization of these cases is presented in Table 3.4. The 
average age for the 11 males with neoplasia was 9.0 years (range 6.4 to 11.5) and for 
the 15 females it was 10.4 years (range 8.2 to 14.6).  
A total of 25 (22.9%) of the captive deaths were attributed to infections or 
inflammation. This include 6 cases with multisystemic involvement, 6 pulmonary, 5 
hepatic, 2 pancreatic, 2 gastrointestinal, 2 neurological, 1 urogenital, and 1 
integumentary. There were two instances in which captive pups exhibited severe 
neurological symptoms and were ultimately euthanized. At post mortem, both pups 
were diagnosed with meningoencephalitis. The etiological agent in one case was a 
protozoan, possibly Sarcocystis neurona and in the other it was the microsporidia, 
Encephalitozoon cuniculi.  
Of the 109 marmot mortalities that occurred in captivity, 17 (15.6%) were 
attributed to  management or captive conditions. Six weaned pups were fatally 
attacked by older, non-related marmots after they escaped through the mesh of their 
natal enclosures. Four of the 61 wild-caught marmots died in quarantine during the 
intial transition to captive conditions. Three of these deaths were attributed to 
bacterial infections and one resulted from a cecal perforation arising from the 
microbial alterations associated with a new, captive diet. One marmot died from 
trauma associated with a fall in its enclosure and one was euthanized following 
elbow trauma of unknown origin. A captive pup scheduled for release experienced 
an extreme, chronic inflammatory reaction to its implanted transmitter, resulting in 
significant encapsulation and visceral adhesions which could not be surgically 
resolved. Two captive marmots died of hypothermia after being exposed to 
hibernation temperatures of -7° C while occupying an outdoor nest-box. 
84 
 
 
From the winter of 1997/98 to the winter of 2015/16 there were a total of 1651 
individual marmot hibernations in captivity with 26 mortalities, indicating a success 
rate of 98.4%. Over the course of these 19 winters there were 547 pup hibernations 
(first winter) and 264 yearling hibernations (second winter) in captivity, with only 1 
pup mortality.  There was an additional adult mortality in December 2016, bringing 
the total number of captive hibernation mortalities to 27. Underlying pathology was 
identified in 24 of these hibernation deaths. Mortality occurring during captive 
hibernation most typically involved older marmots with identifiable health 
problems. This included 12 cases of cardiovascular disease, 4 cases of neoplasia, and 
1 case of cardiovascular disease in combination with neoplasia. Three older marmots 
also succumbed to infections or inflammation during hibernation. The hibernation 
deaths of 4 younger captive marmots also were attributed to infection or 
inflammation. At least some of these mortalities appear to be bacterial or fungal in 
origin. However, most hibernation mortalities were not immediately recovered, and 
therefore, microbiology results should be interpreted with caution (de With et al. 
1999).  
 
 
 
 
 
 
 
 
 
 
  
85 
 
 
Table 3.2. Clinical conditions initially identified from 3,174 Vancouver Island 
Marmot (Marmota vancouverensis) physical examinations. A total of 944 marmots 
were examined, including 632 captive individuals and 353 wild individuals. Sixty-
two marmots were examined following release from captivity.  
 
Category Diagnosis 
Occurrence in 
free-ranging 
marmots 
(wild & 
captive 
release) 
Occurrence 
in captive 
marmots 
Comments 
cardiovascular persistent tachycardia 0 1 heart rate consistently above 300 bpm 
cardiovascular acquired cardiac disease 0 28+ cardiac murmur 
congenital / early onset atrial septal defect 0 1 
identified in wild-caught, captive 
yearling exhibiting un-thriftiness 
congenital / early onset patent foramen ovale  0 1 cardiac murmur 
congenital / early onset dental malocclusions 0 2 
overgrowth of upper and lower incisors 
(both cases were litter-mates) 
congenital / early onset post weaning un-thriftiness 
2 
wild 
2 significantly smaller than litter-mates 
congenital / early onset 
unilateral anopthalmis / 
scoliosis / stunting 
0 1 
captive-born marmot which was the 
progeny of wild-caught parents  
congenital / early onset hind foot aplasia 0 1   
congenital / early onset bilateral, congenital cataracts  0 2   
congenital / early onset 
unilateral, narrowed palpebral 
fissure 
0 1   
iatrogenic / management transmitter reaction 0 1 large abdominal mass 
infectious / inflammatory menigoencephalomyelitis  0 2 depression, ataxia  
infectious / inflammatory facial abscess 
1? 
wild 
7+ unilateral facial swelling 
hibernation post hibernation emaciation 
1           
captive-
release 
0 
extreme emaciation and depression in 
captive-release marmot  
miscellaneous abdominal hernia 0 1 
palpation of fluctuant peri-abdominal 
mass 
miscellaneous 
degeneration and herniation of 
intervertebral disc(s) 
0 2 acute hind-end paralysis 
miscellaneous paraphimosis  0 1 
possibly associated with neurological 
symptoms 
neoplasia facial neoplasia 0 7 
epistaxis, facial assymetry, unilateral 
exopthalmus 
neoplasia other neoplasia 0 3 emaciation  
parasitic mites 
25 
wild 
8 
poor hair coat and hair loss, only 
occurred in wild-born marmots originally 
from Mount Washington 
parasitic cutaneous myiasis  0 1 
bot fly larvae infesting skin of ventral 
abdomen 
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Table 3.2. (cont.) Clinical conditions initially identified from 3,174 Vancouver 
Island Marmot (Marmota vancouverensis) physical examinations. A total of 944 
marmots were examined, including 632 captive individuals and 353 wild 
individuals. Sixty-two marmots were examined following release from captivity.  
 
Category Diagnosis 
Occurrence in 
free-ranging 
marmots 
(wild & 
captive 
release) 
Occurrence 
in captive 
marmots 
Comments 
traumatic 
unilateral / bilateral fractures of 
incisors 
0 2 
impaired regrowth of incisors following 
trauma  
traumatic fracture of carpal bones 
1 
wild 
0 lameness 
traumatic 
chronic fracture of right 
olecranon  
0 1 lameness 
traumatic head trauma 0 1 head tilt 
traumatic? 
resorption of head and neck of 
femur  
0 1 lameness 
traumatic? unilateral, corneal opacity 
1 
wild 
1   
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Table 3.3. Categories of mortality observed in 109 captive Vancouver Island 
Marmots (Marmota vancouverensis), 1997 to 2016. 
 
 
Diagnostic category 
No. 
Cases  
% 
cardiovascular 29 26.6 
infectious / inflammation 25 22.9 
neoplasia 21 19.2 
iatrogenic / management (a) 13 11.9 
congenital / early onset (b) 6 5.5 
cardiovascular & neoplasia 5 4.6 
quarantine (a) 4 3.7 
unknown 3 2.8 
intervertebral disc 
degeneration 
2 1.8 
mesenteric torsion 1 0.9 
 
(a) Iatrogenic / management was defined as any mortality directly related to the 
marmots being manipulated or confined in captivity. This included 
conspecific trauma, falls in enclosures, inappropriate hibernation 
temperatures and transmitter reactions. Death during the quarantine period 
was also attributed to captive confinement.  
(b) Early onset was defined as any condition diagnosed at the time of first 
examination either ante-mortem or post-mortem.  
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Figure 3.2. Sex-age distribution of 109 mortalities in captive, weaned Vancouver 
Island Marmots (Marmota vancouverensis), 1997 to 2016.  
 
 
 
Figure 3.3. Sex-age distribution of 518 mortalities in free-ranging Vancouver Island 
Marmots (Marmota vancouverensis), 1992 to 2016. 
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Table 3.4. Anatomical description of neoplasia in 26 captive Vancouver Island 
Marmots (Marmota vancouverensis) 1997 to 2016. 
 
Anatomical description 
No. 
Cases 
% 
pulmonary 6 23.1 
hepatic 6 23.1 
facial - oral 3 11.5 
facial - periorbital 3 11.5 
fascial - nasal 1 3.8 
splenic 2 7.7 
abdominal 1 3.8 
adrenal 1 3.8 
mammary 1 3.8 
uterus 1 3.8 
multi-systemic 1 3.8 
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Mortality in Free-ranging Marmots: From 1992 to the completion of the 2016 field 
season, a total of 533 confirmed mortality records were generated from free-ranging 
marmots. This included records for 183 wild marmots (including 44 translocated 
marmots) and 350 captive-release marmots (including 20 pre-conditioned marmots). 
Implanted marmots accounted for 515 (96.6%) of the mortality records. There were 
also 15 records in which field workers encountered the remains of unidentified 
marmots. In 5 of these cases, old or desiccated marmot remains (mostly small 
numbers of disarticulated bones and clumps of hair) were found in proximity to 
burrow entrances and were presumably pushed out of the burrow by other 
marmots. Although it is probably reasonable to assume that these marmots died 
underground, the timing of their deaths could not be reliably determined, and 
therefore the cause of death in these marmots was categorized as ‘unknown’.  
Causes of mortality of free-ranging marmots are summarized in table 3.5 and 
the sex-age distribution of these mortalities is summarized in Figure 3.3. The 
average age of males was 3.28 years (range 0.2 to 9.5) and the average female age 
was 3.57 years (range 0.2 to 13.1).   
Wild marmots 
From 1992 to 2016 a total of 379 implant surgeries were performed on wild 
marmots, including 63 replacement surgeries (total = 316 individuals). Mortality was 
confirmed in 167 or 52.8% of these implanted wild marmots. Only 7 (2.1%) of these 
telemetered marmots (4 wild and 3 translocated) were recovered in a condition 
which was suitable for a post mortem examination. The necropsy results for these 7 
marmots (and one un-telemetered individual) are presented in Table 3.7.  
Four of these 7 wild marmots died following manipulation, including one 
individual which died from acute hyperthermia following handling and field 
surgery in 1992, and three translocated individuals which were recovered from their 
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hibernaculum in the spring of 1997 after a failed translocation attempt. A fourth 
marmot mortality from this same group could not be retrieved. These translocated 
marmots died during hibernation despite exhibiting good body stores and a 
definitive cause of death was not identified despite intensive investigation (de With 
et al. 1999). In addition to these four related mortalities, there was one other record 
of a translocated marmot that failed to emerge in the spring and its transmitter 
remained underground on a slow pulse.  
The intact carcass of a wild, telemetered marmot was recovered in May 2005 
and post-mortem examination indicated that although it had been actively feeding 
aboveground (as evidenced by ingesta in its gastrointestinal tract) it had probably 
died of post-emergence emaciation. In 7 other instances, wild (non-translocated) 
telemetered marmots failed to emerge from their burrows in the spring, and their 
transmitters remained underground on a slow pulse rate. Only 1 of these 8 
hibernation mortalities involving wild marmots occurred in the winter that followed 
implant surgery, with the remainder dying during subsequent winters.   
Captive-release 
From 2003 to 2016 a total of 490 captive marmots were released to the wild 
(annual numbers summarized in Figure 1.2 and Appendix A), including 482 captive-
born individuals and 8 wild-born individuals. A total of 485 of the captive-release 
marmots were surgically implanted with an abdominal radio transmitter for post 
release tracking and 33 of these individuals were later recaptured and had their 
transmitters replaced. Two of the 490 released marmots (one implanted, one not 
implanted) were recaptured and permanently returned to the captive breeding 
program. Mortality was confirmed in 349 (72.1%) of the 484 marmots fitted with 
radio transmitters that remained in the wild.  
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Only 22 or 4.55% of the 484 telemetered marmots were recovered in a 
condition that was suitably intact for a post mortem examination. In addition, a 
single un-telemetered, post-release marmot was recovered after drowning in a 
reservoir. No pre-conditioned marmots were recovered for necropsy. The necropsy 
results for these 23 intact, post-release marmots are presented in Table 3.8.  
Ten of the 23 post-release marmots presented for necropsy were diagnosed 
with post-emergent emaciation as the proximate cause of death. These marmots 
were discovered in May or early June. Eight of these marmots were found 
aboveground and two were dug out of a shallow hibernaculum. Telemetry on these 
latter two marmots indicated that their body temperatures were still cycling into 
periods of euthermy late into the spring before they died in their burrow. Another 
post-emergent marmot was still alive when it was recovered by field staff but 
perished while being transported into care. Extreme weight loss and loss of fat stores 
in a post-emergent, adult male may have resulted in an abdominal radio-transmitter 
becoming lodged in its pelvic canal, resulting in a fatal impaction of the 
gastrointestinal tract. At least one of the recently emerged marmots was found dead 
at the hibernaculum entrance, and it is possible that burrowing out through deep or 
frozen snow placed an additional burden on the marmot’s limited energy stores.  
In addition to the 10 cases where an intact carcass was recovered, there were 
75 additional records (70 captive-release, 5 pre-conditioned) where post-release 
marmots died during hibernation. In these cases, a marmot failed to emerge from 
hibernation and its radio-transmitter continued to transmit a slow-pulse (i.e. low 
temperature) signal from the hibernaculum. Two marmots appeared to have 
emerged from hibernation and then died in their burrows shortly afterward. In at 
least two instances, a whole group of marmots failed to emerge from hibernation, 
and in at least two others, an individual marmot survived, whereas its burrow-
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mates did not. Of the 80 hibernation mortalities documented in post-release 
marmots (excluding pre-conditioned marmots), 76 occurred in the first winter 
following release from captivity and 4 died during subsequent winters. Death 
during hibernation accounted for 44.4% of the captive-release mortalities for which 
there was an identified cause (N = 171), compared to 9.5% for unmanipulated (non-
translocated), wild marmots (N = 84). Predation accounted for 166 or 31.1% of the 
533 mortalities in free-ranging marmots (Table 3.6). Mortalities attributed to 
predators are summarized according to year in Figure 3.4.   
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Table 3.5. Categories of mortality for wild, translocated, captive-release and pre-
conditioned Vancouver Island Marmots (Marmota vancouverensis) including post 
mortem reports and mortality records, N = 533.   
 
 
Wild (n = 139) No. Cases % 
Predation 73 52.5 
Hibernation 8 5.8 
Other 3 2.2 
Unknown 55 (a) 39.6 
Translocated (n = 44) No. Cases % 
Predation 5 11.4 
Hibernation 5 11.4 
Other 0 0.0 
Unknown 34 77.3 
Captive-release (n = 330) No. Cases % 
Predation 86 26.1 
Hibernation 80 24.2 
Other 5 1.5 
Unknown 159 48.2 
Pre-conditioned (n = 20) No. Cases % 
Predation 2 10.0 
Hibernation 5 25.0 
Other 0 0.0 
Unknown 13 65.0 
 
(a) This includes 16 records involving the remains of unidentified wild 
marmots encountered by field staff. 
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Table 3.6. Predator mortality for wild, translocated, captive-release and pre-
conditioned Vancouver Island Marmots (Marmota vancouverensis) from 1992 to 
2016 (total = 166).  
 
 
 
 Cougar 
Golden 
Eagle 
Grey 
Wolf 
Black 
Bear 
Avian 
(a) 
Dog Unknown 
Wild                               
(n = 73) 
38 8 9 0 1 1 16 
Translocated                           
(n = 5) 
0 1 2 0 0 0 2 
Captive-release             
(n = 86) 
38 25 8 1 0 0 14 
Pre-conditioned   
(n = 2) 
0 1 0 1 0 0 0 
Total 76 35 19 2 1 1 32 
 
 
(a) Marmot pup killed by avian predator, possibly Northern Goshawk (Accipiter gentilis) 
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Figure 3.4. Yearly predation mortalities of free-ranging Vancouver Island Marmots (Marmota vancouverensis) from 
1992 to 2016 (total = 166).  
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Table 3.7. Post mortem diagnosis in 8 (7 telemetered, 1 non-telemetered) wild 
Vancouver Island Marmots (Marmota vancouverensis) 1992 – 2016. 
 
Diagnostic category Comments 
No. 
Cases 
hibernation 
group of 4 died in hibernaculum after failed 
translocation, 3 carcasses recovered (2 
telemetered, 1 un-telemetered), etiology not 
determined 
3 
hibernation 
post-emergent emaciation            
found aboveground 
1 
iatrogenic hyperthermia from handling & surgery 1 
infectious hepatic abscess in a ten-year old female 1 
predation suspect domestic dog 1 
unknown post mortem inconclusive 1 
 
 
Table 3.8 Post mortem diagnosis in 23 (22 telemetered, 1 non-telemetered) captive-
release Vancouver Island Marmots (Marmota vancouverensis) 2003 – 2016. 
 
Diagnostic 
category 
Comments 
No. 
Cases 
% 
hibernation              
(total =10) 
post-emergent emaciation, found 
aboveground 
8 34.8 
group of 2 recovered in shallow hibernaculum 2 8.7 
predation (4) 
Golden Eagle 3 13.0 
Cougar 1 4.3 
drowning fell into reservoir 2 8.7 
trauma fall from cliff 1 4.3 
suspected trauma lesions suggested traumatic injury 1 4.3 
iatrogenic transmitter impaction in pelvis 1 4.3 
unknown post mortem inconclusive 3 13.0 
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DISCUSSION 
The Vancouver Island Marmot recovery project has collected extensive 
information on both free-ranging and captive marmots, and from these data it is 
apparent that captive, wild and captive-release marmots are subjected to disparate 
assemblages of health determinants and exhibit different spectrums of health 
outcomes. In addition, there are significant differences in the capacity to collect 
health data and conduct surveillance on these populations.  
In captivity, VIM can be observed on a regular basis, and any suspected 
abnormalities in behaviour, appetite, excretion, or physical appearance (body 
condition, symmetry, posture, locomotion, hair coat, etc.) can be promptly 
recognized, evaluated, and monitored. In addition, captive marmots were routinely 
examined on an annual or biennial basis. Ninety-six per cent of the captive 
mortalities were efficiently identified and extensively investigated. Intensive 
observation, clinical evaluation, and post mortem examination of captive marmots 
resulted in the description of a number of health conditions. Although many of these 
conditions would present grossly observable signs, most were not identified in the 
numerous physical examinations that were conducted on free-ranging VIM 
(Appendix G). However, it is important to note that physical examinations were 
only conducted on those free-ranging individuals that could be successfully live-
trapped and this may represent an important distinction in sampling between the 
captive and free-ranging populations. It is always possible that the health of some 
free-ranging marmots may have been compromised, and that the adaptive 
behavioral responses associated with “sickness behavior” precluded these marmots 
from being active and trappable above-ground (Hart, 1988). Predation, scavenging, 
ambient conditions, and delays in recovery reduced the effectiveness of mortality 
investigation in free-ranging marmots. Site accessibility also represented a 
99 
 
 
significant challenge in determining the occurrence, timing and causes of mortality 
in the field, and this varied greatly between locations. It is possible that the small 
number of intact carcasses that were recovered in the field for post mortem 
examination (31) also reflected the low number of non-predatory deaths that occur 
in the free-ranging population.  
One of the original objectives of the captive program was to establish a 
safeguard population, so that marmots could be maintained under controlled 
conditions without being exposed to the multiple threats that exist in the wild. 
However, captivity is not entirely benign and artificial conditions appear to have 
imposed a new set of risk factors for Vancouver Island Marmots. Cardiovascular 
disease was quite prevelent in captive male marmots and its onset was earlier than 
in females. Cardiomyopathy has been documented in other rodent species including 
woodchucks (Marmota monax),  Norway rats (Rattus norvegicus) and black rats 
(Rattus rattus) (Roth & King, 1986). In laboratory rats, cardiomyopathy is most 
prevelent in older males and the severity and age of onset are influenced by a 
number of factors including stress, nutrition, and ambient conditions (Rothenburger 
et al. 2014). Obesity has also been recognised as an important risk factor for 
cardiomyopathy in a number of other species (Wong & Marwick, 2007). In captivity, 
Vancouver Island Marmots exhibit a shorter hibernation period, receive less 
exercise, are subject to increased hygiene and parasite control, and are fed a more 
protracted, uniform, and nutritionally-concentrated diet than their wild 
counterparts. A comparison between in situ and ex situ marmots shows that body 
condition indices were consistently and significantly higher in captive animals, 
indicating a higher level of adiposity which may be increasing their suseptibility to 
cardiomyopathy (Appendix H).  
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Hibernation mortalities occurred infrequently in captivity and most typically 
involved older marmots with identifiable health problems. Mortality records from 
this project support previous research indicating that death during hibernation also 
is an uncommon occurrence in wild, unmanipulated VIM (Bryant & Page, 2005). 
Low hibernation mortality also has been documented for other species, including 
the Olympic marmot (Marmota olympus) (Griffin et al. 2008). Differentiating between 
hibernation mortality and the mortality that occurs shortly before or after 
hibernation is difficult, and verification of high winter survival in both Vancouver 
Island and Olympic marmots required intensive monitoring using radiotelemetry.  
Conversely, hibernation mortality appeared to be significant in marmots 
released from captivity. Records from this project indicated that 76 of the 80 
hibernation mortalities in captive-release marmots occurred during the first winter 
following release. Reduced overwinter survival during the first hibernation may 
represent a significant limiting factor for the marmot reintroduction program 
(Jackson, 2005). Captive VIM typically have shorter hibernations than wild marmots, 
and the difference in duration can be several weeks or longer (Bryant & McAdie, 
2003). Although marmot life cycles are controlled by endogenous, circannual 
rhythms, these can be readily altered by certain exogenous factors, such as 
temperature, photoperiod, and food availability. Modification of endogenous cycles 
has the potential to disrupt growth, patterns of food consumption, reproduction and 
hibernation and these asynchronous cycles can be entrained for an extended period 
of time (Concannon et al. 1997). It is possible that captive-release marmots are 
released with aberrant endogenous cycles and as a result have disrupted hibernation 
patterns that compromise their first hibernation in the wild.  
For wild and captive-release VIM, predation represented the most significant 
cause of mortality. Predation has been implicated as an important factor in the 
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original population declines of this species (Bryant & Page, 2005; Janz et al. 2000) and 
as a significant cause of mortality in captive-release marmots (Aaltonen et al. 2009). 
During the original population declines that occurred in the late 1980s and 1990s, 
Wolves, cougars, and eagles were thought to represent important predators of VIM 
(Janz, et al. 2000). Aaltonen, et al. 2009 concluded that cougars and wolves were the 
most important predator for wild marmots and that Golden Eagles represented the 
most significant predator for captive-release marmots. In recent years, the influence 
of the respective predators appears to have changed. No wolf predations of 
telemetered marmots have been recorded since 2009 and no mortalities from Golden 
Eagles have been documented since 2014. During the 1990s, adult and juvenile 
Golden Eagles were routinely observed at active and extirpated marmot colonies, 
but sightings by field staff in recent years have become quite uncommon (Marmot 
Recovery Foundation inventory records). Over the last eight years, cougars appear 
to represent the biggest predation threat to be detected in wild and captive-release 
marmots (Figure 4).  
Physical examinations conducted by experienced veterinarians, necropsies 
performed by veterinary pathologists, and observations made by field staff offer 
reliable and robust health-related data. Based upon this study, the systematic 
collection and evaluation of these data allows for the identification and 
characterization of potential patterns, clusters, or syndromes and the recognition of 
potential health and health risk patterns in the VIM. Although the captive 
population was characterized by increased longevity, it also exhibited a greater 
number of clinical syndromes, not all of which were age-related. Intensive 
management and support in captivity may allow some affected animals to survive 
for a longer period of time than their wild counterparts, and potentially reproduce. 
If any of these conditions have a genetic basis, there is a potential risk that these 
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characteristics will be perpetuated within the captive population. Captive-release 
marmots exhibited poor survival in their first wild hibernation. More rigorous 
management of food availability, light and temperature regimes in captivity (that 
more closely mimic natural cycles) may help to normalize hibernation patterns and 
increase post-release survival. 
There was very little evidence of clinical disease in the free-ranging marmots 
that were examined following capture for implant surgery or translocation. 
However, this population had very few older individuals and opportunities to 
evaluate them through physical and post mortem examinations were very limited. 
Despite this limitation, site investigations were able to identify potential causes of 
mortality in free-ranging marmots that could be influencing marmot recovery. 
Predation continued to represent the most significant cause of mortality in free-
ranging marmots and recent declines in the wild population may indicate that it is 
still too small to overcome ongoing predation pressure. Predator-pits have been 
described in other species including lemmings and rabbits (Calvete et al. 1997; Krebs, 
1996) and it is possible that enhanced augmentation or predator management may 
be necessary for the VIM to overcome the current effects of predation.  
With endangered species like the VIM, it is possible that health events with 
significant implications may only be expressed in a small number of individuals and 
may therefore lack numerical or statistical robustness. In addition, case 
documentation often involves the collection of incomplete or discrepant data. 
Syndromic surveillance appears to provide a conceptual framework for the ongoing 
characterization and comparison of these case limited or incomplete health events, 
and facilitates detection, evaluation and tracking of patterns or clusters as they are 
occurring. This allows for filtering and efficient transfer of health information so that 
ongoing risks can be identified and further investigated, and so that timely, 
103 
 
 
evidence-based decisions can be made. It is important to recognize that for this 
approach to be effective in the long-term, the monitoring process needs to be 
continual and dynamic in nature, so that new data originating from the multitude of 
sources are properly integrated, contextualized, and adapted with respect to 
previously identified events and patterns. The range of potential influences and 
risks elucidated in this study support the importance of continued surveillance with 
respect to the health management and recovery of the Vancouver Island Marmot. 
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CHAPTER 4 
CONCLUSION 
 
The overarching goal of this thesis was to expand upon our understanding of 
individual and population health in the critically endangered Vancouver Island 
Marmot (Marmota vancouverensis). My approach was to describe and evaluate select 
clinical and pathological data originating from a variety of sources. This involved 
the analysis of 1,106 Vancouver Island Marmot (VIM) blood profiles, 3,174 physical 
examinations, 140 necropsies, and 533 field mortality records. In Chapter 2, I 
calculated hematology and serum biochemistry reference ranges as a baseline metric 
for assessing VIM health. I also determined that VIM blood values are qualitatively 
comparable to those that have been calculated for other rodent species and that 
certain leukogram and plasma protein values may have potential utility as a 
quantitative measure for comparing VIM management groups. In Chapter 3, I use 
physical examinations, post mortem examinations, and field evaluation of marmot 
mortalities, to identify health trends in captive, captive-release and wild VIM. These 
analyses sought to determine what is expected for this species under different 
conditions (wild, captive and captive-release) and to identify potential risk factors 
that may be influencing the species’ capacity to achieve or maintain health and to 
meet defined recovery objectives.  
 
DEFINING HEALTH IN THE VANCOUVER ISLAND MARMOT 
The relative state of health of a wildlife population is not necessarily defined 
by a discrete set of biological characteristics but by human expectations and 
constructs (Stephen, 2014) which seek to identify an ideal standard of population 
well-being (Hanisch, et al. 2012). With the formulation of officially recognized 
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conservation strategies, the VIM’s health status is determined by the species’ relative 
capacity to fulfill discrete recovery objectives with specific numerical, spatial, and 
temporal components. Evaluating the population’s health includes the identification 
and assessment of determinants and outcomes which are compatible with, or which 
compromise, the species’ capacity for achieving normative recovery goals. VIM 
health is contingent upon many factors including the attributes of the animals, their 
environment, the presence or absence of tangible, effective recovery actions, and the 
logistical and socio-economic feasibility of implementing these actions. 
 
THERE IS NOT ONE HEALTH FOR VIM 
It is important to recognize that health in the Vancouver Island Marmot 
cannot be characterized by a singular, uniform state. Recovery efforts for VIM have 
involved an intensive program of captive breeding and conservation translocations, 
requiring the monitoring and management of several groups or subpopulations. 
These include; (A) the original in situ population that was under threat and 
demonstrating dramatic declines, (B) the captive founder population consisting of 
wild-born individuals captured and transitioned to the artificial conditions of 
captivity, (C) the ex situ population comprised of captive-born animals raised under 
the artificial conditions of captivity, (D) the captive-release population consisting of 
captive individuals transitioning back to the wild, and (E) the free-ranging recovery 
population consisting of successful captive-release marmots, their progeny and the 
descendents of the original wild marmots. Each of these groups has been subject to a 
unique set of natural and artificial determinants which have influenced health 
outcomes and expectations. There are also significant differences in the extent to 
which each of these groups can be monitored and manipulated. However, from a 
conservation and management perspective, the relative state of health of the 
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subpopulations will collectively influence the species’ capacity to achieve recovery 
objectives. If the health of one group is compromised, it has the potential to 
jeopardise the integrity of the other groups and affect species recovery overall.  
The original in situ population  
In the 1980s and 1990s, there was dramatic destabilization of the VIM 
population and it suffered severe declines. As a result, the wild population was no 
longer autonomous and self sustaining, and it was deemed to be incapable of 
independently achieving recovery targets (Janz, et al., 2000). The original population 
declines had been attributed to demographic and ecosystem effects (Janz, et al., 
2000), but there was insufficient historical data for this analysis to consider whether 
changes to marmot health may also have been a contributing factor.  
The ex situ population  
Captivity is not entirely benign and artificial conditions posed a novel set of 
risk factors for VIM, particularly as management and husbandry practices were in 
their initial stages of development. Regular observation, routine clinical evaluation, 
and thorough post mortem examination of captive individuals resulted in the 
description of a number of health conditions not identified in any free-ranging 
marmots. For example, intensive management and protection in captivity appears to 
have led to increased marmot longevity, allowing for the appearance of age-related 
problems such as acquired cardiovascular disease and neoplasia, which collectively 
accounted for approximately 50% of captive mortalities. As captive marmots age, it 
is possible that obesity may represent an increased risk factor for these disorders. 
Although there were congenital defects identified in the captive population, they 
did not occur with enough frequency or predictability to suggest a progressive 
increase in the number of genetically compromised individuals or in the level of 
inbreeding (Pimm et al., 2006; Raikkonen et al., 2006). None of the individuals 
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displaying congenital disorders were allowed to breed in captivity and since 2011 no 
congenital problems have been been identified in the captive population.  It is 
possible that captive support may have prolonged the survival of young marmots 
suffering from these abnormalities.  
Overall, the captive population has proven effective in meeting its defined 
objectives, which includes acting as a long-term safeguard, a genetic reservoir, and a 
provider of marmots for release. The captive program’s future health, and its 
capacity for continuing to achieve recovery targets, appears to be dependent upon 
the continued maintenance of effective biosecurity measures and a suitable captive 
population size, which allows for the proper maintenance of genetic integrity. A 
viable captive program is dependent upon political will and adequate resources.   
The captive-release and free-ranging recovery population  
Captive-release marmots have been documented to have lower survival than 
their wild-born counterparts, and this is most apparent in their first year following 
release from captivity (Aaltonen et al., 2009). The first hibernation in the wild 
represented a significant cause of mortality and it is possible that captive marmots 
are released with shortened or abberent endogenous cycles which may compromise 
their initial hibernation. There are limited data on the fall body mass of captive-
release marmots, but it is also possible that poor body condition at the time of 
immergence or emergence could also jeopardise overwinter survival. Captive-
release marmots that survive their first winter in the wild exhibit subsequent 
hibernation survival that is comparable to their wild counterparts. Although 
marmots released from captivity do survive and facilitate growth of the free-ranging 
population (Jackson et al., 2015), it is possible that this contribution could be 
significantly enhanced by increasing survival during their first hibernation.  
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Although captive-release marmots were not routinely trapped and examined 
during their first year following release, they were opportunistically captured, 
examined, and sampled in subsequent years. In terms of physical examinations, 
body condition, bloodwork and occurance of morbidity, these surviving captive-
release marmots were clinically comparable to their wild-born counterparts. Overall, 
there was a paucity of health conditions identified in free-ranging marmots (both 
wild and captive-release) compared to their captive counterparts. This could be due 
to a fundamental lack of disease, or limited opportunities to observe or examine 
compromised marmots due to their reclusive behaviors or poor survival. In addition 
to not being observed or evaluated with the same intensity, in situ marmots did not 
appear to exhibit the same longevity as ex situ animals, thereby limiting the 
appearance of age-related disorders.  
For wild and captive-release Vancouver Island marmots, predation 
represented the most common cause of mortality. In each of these two groups, 
predation accounted for at least 95% of the non-hibernation deaths for which a 
specific cause was identified. Predation has been implicated as an important factor 
in the original population declines of the species (Bryant & Page, 2005; Janz et al. 
2000) and as a significant cause of mortality in captive-release marmots (Aaltonen et 
al. 2009). Mortality records current to the end of the 2017 field season indicate that 
predation continues to be a limiting factor in marmot population growth and 
recovery. Even though the wild population has shown encouraging growth 
associated with reintroductions and translocations, it may still be too small to 
overcome the inhibiting effects of ongoing predation pressure. Similar situations 
have been described for a range of species including lemmings and rabbits (Calvete 
et al. 1997; Krebs, 1996). Like the original in situ population, the current recovery 
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population lacks autonomous sustainability and remains dependent upon captive 
augmentation to achieve defined recovery goals.   
 
INFECTIOUS DISEASE  
Infectious agents have been identified as an important cause of declines in 
many endangered populations (Biedrzycka & Kloch, 2016) and have been suggested 
as a potential threat to VIM (Jackson et al. 2015; Janz et al. 2000; Bryant, 1998). There 
are many examples of rare species being affected by infectious disease, including 
chytridiomycosis in amphibians, canine distemper in Serengeti lions (Panthera leo), 
Ethiopian wolves (Canis simensis) and black-footed ferrets (Mustela nigripes), feline 
leukemia virus in Iberian Lynx (Lynx pardinus) and Plasmodium sp. in Hawaiin land 
birds (Gordon, et al., 2015; Roznik & Alford, 2015; Ewan et al., 2012; Cleaveland, 
2009; Thorne & Williams, 1998). With respect to VIM, this analysis of clinical and 
pathological data did not identify any specific infectious agents in captive or free-
ranging marmots that represented a generalized population threat. However, there 
is always the ongoing risk of future exposure to a novel pathogen. Zoological 
facilities maintain eclectic collections of multiple taxa from a diversity of sources, 
each with their own spectrum of infectious agents (Snyder, et al., 1996). Captive 
facilities may also inadvertently harbour pest species which provide an additional 
reservoir for introduction of exotic pathogens. Although captive VIM are 
maintained under strict biosecurity protocols, quarantine procedures may be 
compromised whenever marmots are transferred between facilities or translocated. 
Also, infectious agents may emerge or be maintained in sympatric or introduced 
species on Vancouver Island. The threat of novel infectious agents cannot be 
quantified because it is impossible to delineate the full spectrum of VIM’s 
suseptibility to infectious agents. This susceptibilty could potentially increase if 
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existing biosecurity measures are relaxed, or if the population experiences 
additional loss of genetic variation and immunocompetence due to a decrease in 
population size (Biedrzycka & Kloch, 2016).  
 
RECOMMENDATIONS    
• Although most of the current threats to the VIM population appear to be 
associated with anthropogenic or ecological factors, artificial management, low 
genetic diversity, and small numbers place the species at additional risk for 
introduction of novel infectious agents and genetic deterioration. Although this 
risk cannot be quantified, continued health surveillance of the captive and free-
ranging populations, using the data from this thesis as a baseline for comparison, 
will help to recognize future changes and identify potential threats.  
• It is possible that existing biosecurity measures in captivity may have acted as an 
effective safeguard against the introduction of novel infectious diseases. These 
precautions are well integrated into existing management protocols and should 
be continued.        
• Obesity may increase the risk for age-related disorders in captive marmots, 
including cardiovascular disease and neoplasia. Management practices, 
including diet composition and seasonal duration of feeding, and how they 
influence body condition and hibernation, should be reviewed.  
• It is possible that congenital problems and mange may be indicative of genetic 
compromise or inbreeding in VIM. Although the occurrence of these disorders 
appears to have abated over time, marmots should be carefully monitored for 
their reappearance. In general, marmots with congenital problems should not be 
allowed to breed and marmots exhibiting mange should not be allowed to breed 
to closely related individuals.      
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• The first wild hibernation results in significant mortality of captive-release 
marmots. Although marmots are confirmed to have good body reserves at the 
time of their release from captivity, it is possible that they may lose condition as 
they transition to a wild environment. This loss may compromise their ability to 
survive their first hibernation. There is a need for further research which 
compares the hibernation characteristics of captive, captive-release, and wild 
marmots and investigates the effects of entrainment of endogenous cycles in 
captivity, marmot body condition at immergence and emergence, hibernacula 
characteristics and the benefits of pre and post-hibernation supplementation.  
• From 1992 to 2016 a total of 898 implant surgeries were performed on VIM 
including 96 replacement surgeries. Two fatal complications (0.22% of total 
surgeries) have arisen directly from implanted transmitters. In one case, the 
radio-transmitter become lodged in the pelvic canal of an emaciated post-
emergent male, resulting in a fatal impaction of the gastrointestinal tract. In the 
second case, the outer surface of the transmitter caused an extreme, chronic 
inflammatory reaction with significant encapsulation and visceral adhesions. 
These problems were subsequently mitigated by having the manufacturer 
increase the diameter of the transmitters and by having the transmitters 
encapsulated in a hard, biologically inert resin. Although there were focal 
adhesions to the greater omentum associated with the early use of wax-coated 
transmitters (1992 to 2010, Appendix D), there was no corrosion, leakage or overt 
breakdown of the radio-transmitters as has been reported in other species 
(Arnemo et al., 2018). Based upon bloodwork, physical examinations (including 
post-surgical evaluations) and necropsies, the implantation of abdominal radio-
transmitters does not appear to impact marmot health, and these units should 
continue to be used to monitor free-ranging marmots. They represent the most 
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effective method for monitoring survival and mortalities in the free-ranging 
population.  
• Although mortalities in free-ranging marmots are generally characterized by 
limited remains and forensic clues, these events should continue to be rigorously 
investigated as part of an expanding data set.  
• Although recovery of intact marmot carcasses from the field is a rare occurrence, 
these events represent significant clinical data and should be comprehensively 
evaluated as opportunities present themselves.  
 
THESIS SIGNIFICANCE 
My thesis extended our understanding of health in the Vancouver Island 
Marmot by collating select clinical and pathological data from multiple sources. It 
described characteristics for blood values, morbidity, and mortality under different 
management treatments (wild, captive and captive-release) and identified potential 
threats to both captive and free-ranging marmots. Although these results are 
important, they are by no means definitive in nature. This analysis is not meant to 
represent an exhaustive or conclusive treatment of VIM health data. The greatest 
utility of this thesis is that it can serve as a template for ongoing comparisons and for 
recognizing change. Marmot health and its influences are complex and dynamic in 
nature, and therefore continued health surveillance and evaluation of existing and 
new data represent important keys for effective management and species recovery.   
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Appendix A. Vancouver Island Marmot (Marmota vancouverensis) captive population numbers from 1997 to 2018.   
Y
e
a
r 
W
il
d
 m
a
rm
o
t 
c
a
p
tu
re
s
 
e
x
c
lu
d
in
g
 p
u
p
s
 
(2
6
) 
  
  
  
  
  
 
W
il
d
 p
u
p
 
c
a
p
tu
re
s
 (
4
5
) 
T
o
ta
l 
w
il
d
 
c
a
p
tu
re
s
 (
7
1
) 
W
e
a
n
e
d
 c
a
p
ti
v
e
 
li
tt
e
rs
 (
1
8
0
) 
B
re
e
d
in
g
 P
a
ir
s
 
(f
ro
m
 2
0
0
5
 t
o
 
2
0
1
8
) 
P
ro
p
o
rt
io
n
 o
f 
P
a
ir
s
 B
re
e
d
in
g
 
(2
0
0
5
 t
o
 1
8
) 
W
e
a
n
e
d
 c
a
p
ti
v
e
 
p
u
p
s
 (
6
1
2
) 
  
  
  
  
  
  
 
W
e
a
n
e
d
 m
a
le
s
  
 
(5
6
%
) 
W
e
a
n
e
d
 f
e
m
a
le
s
 
(4
4
%
) 
U
n
k
n
o
w
n
 
A
v
e
ra
g
e
  
  
  
  
  
  
w
e
a
n
e
d
  
  
  
  
 
li
tt
e
r 
s
iz
e
 
C
a
p
ti
v
e
 
M
o
rt
a
li
ti
e
s
 (
1
1
3
) 
  
  
  
 
R
e
le
a
s
e
s
 o
f 
c
a
p
ti
v
e
 
m
a
rm
o
ts
 (
5
1
5
) 
  
  
  
  
  
  
  
 
R
e
c
a
p
tu
re
s
 (
2
) 
 
C
a
p
ti
v
e
 T
o
ta
l 
  
  
  
  
  
  
  
  
  
 
(5
8
) 
  
  
  
  
  
  
1997 4 2 6 0     0 0 0 0 0.00 0 0 0 6 
1998 5 3 8 0     0 0 0 0 0.00 2 0 0 12 
1999 9 10 19 0     0 0 0 0 0.00 4 0 0 27 
2000 1 4 5 2     8 5 3 0 4.00 1 0 0 39 
2001 2 5 7 1     2 1 1 0 2.00 1 0 0 47 
2002 2 4 6 5     13 8 5 0 2.60 3 0 0 63 
2003 1 2 3 7     18 10 8 0 2.57 4 4 1 77 
2004 0 1 1 8     26 19 7 0 3.25 2 9 0 93 
2005 0 0 0 13 26 0.50 48 31 17 0 3.69 5 15 0 121 
2006 0 0 0 14 30 0.47 55 27 28 0 4.00 4 31 1 142 
2007 0 0 0 15 37 0.41 60 33 27 0 4.00 3 37 0 162 
2008 0 0 0 23 46 0.50 85 41 40 4 3.70 11 59 0 177 
2009 0 0 0 20 48 0.42 71 33 38 0 3.55 9 68 0 171 
2010 0 0 0 18 49 0.37 55 33 22 0 3.06 11 85 0 130 
2011 0 0 0 18 36 0.50 51 26 24 1 2.83 8 66 0 107 
2012 0 0 0 6 26 0.23 22 11 11 0 3.66 9 34 0 86 
2013 0 0 0 6 25 0.24 18 11 7 0 3.00 6 16 0 82 
2014 0 0 0 6 19 0.36 18 10 8 0 2.83 16 29 0 55 
2015 0 0 0 5 12 0.42 15 9 6 0 3.00 1 24 0 45 
2016 1 5 6 3 14 0.21 13 8 5 0 4.33 9 13 0 42 
2017 0 2 2 5 11 0.45 19 12 7 0 3.80 3 11 0 49 
2018 1 8 9 5 12 0.42 15 11 4 0 3.00 1 14 0 58 
Total  26 46 72 180 391 0.40 612 339 268 5 3.40 113 515 2 58 
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Appendix B. Descriptive statistics for hematological variables from clinically normal or healthy Vancouver Island 
Marmots (Marmota vancouverensis) before & after removal of outliers. Used in calculation of reference values in 
accordance with guidelines established by Species 360, formerly the International Species Information System (Teare, 
2002). 
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M
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N S.
D
. 
WHITE BLOOD CELLS                                 
White blood cells WBC x 10⁹/L 5.1 0.6 35.9 1030 2.4 7.1 -2.0 12.2 12.0 5.0 0.6 12.2 1018 1.9 
Segmented neutrophils Neutro x 10⁹/L 2.7 0.3 26.6 1027 1.6 4.8 -2.1 7.6 10.0 2.6 0.3 7.6 1017 1.2 
Band neutrophils Bands x 10⁹/L 0.0 0.0 0.5 1027 0.0 0.1 -0.1 0.1 15.0 0.0 0.0 0.0 1012 0.0 
Lymphocytes Lympho x 10⁹/L 2.0 0.0 12.0 1027 1.2 3.7 -1.7 5.6 9.0 1.9 0.0 5.5 1018 1.1 
Monocytes Mono x 10⁹/L 0.3 0.0 6.1 1027 0.4 1.1 -0.7 1.4 15.0 0.3 0.0 1.4 1012 0.3 
Eosinophils Eosino x 10⁹/L 0.0 0.0 1.1 1027 0.1 0.2 -0.2 0.3 16.0 0.0 0.0 0.2 1011 0.0 
Basophils Baso x 10⁹/L 0.0 0.0 0.3 1027 0.0 0.1 -0.1 0.1 24.0 0.0 0.0 0.1 1003 0.0 
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Appendix B (cont.) Descriptive statistics for hematological variables from clinically normal or healthy Vancouver 
Island Marmots (Marmota vancouverensis) before & after removal of outliers. Used in calculation of reference values 
in accordance with guidelines established by Species 360, formerly the International Species Information System. 
(Teare, 2002) 
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. 
ERYTHROCYTES                                 
Red blood cells RBC 
x 10 
¹²/L 
6.4 2.8 8.9 1025 0.7 2.2 4.3 8.6 15.0 6.4 4.2 8.5 1010 0.6 
Hemoglobin Hb g/L 144.4 15.0 198.0 1016 16.2 48.7 95.7 193.0 12.0 145.1 98.0 187.0 1004 14.3 
Hematocrit Hmt L/L 0.4 0.2 0.6 1030 0.0 0.1 0.3 0.6 9.0 0.4 0.3 0.6 1021 0.0 
Mean corpuscular 
volume 
MCV fl 65.8 5.1 92.7 992 5.6 16.7 49.1 82.5 15.0 65.9 50.0 82.3 977 3.5 
Mean corpuscular 
hemoglobin 
MCH pg 22.4 16.3 33.1 986 1.6 4.8 17.6 27.2 0.0 22.4 16.3 33.1 986 1.6 
Mean corpuscular 
hemoglobin 
concentration 
MCHC g/L 339.5 253.0 493.0 996 15.3 46.0 293.6 385.5 13.0 339.3 294.0 384.0 983 12.3 
Red cell distribution 
width 
RCDW %CV 14.3 5.2 30.3 904 2.1 6.4 7.9 20.7 27.0 14.4 10.1 20.3 877 1.5 
HEMOSTASIS                                 
Platelet count   x 10⁹/L 323.0 37.0 1295.0 767 104.9 314.6 8.3 637.6 6.0 318.7 37.0 625.0 761 91.7 
Mean platelet volume   fl 8.9 0.0 16.9 704 1.4 4.3 4.6 13.2 10.0 8.9 6.7 14.0 694 1.3 
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Appendix B (cont.) Descriptive statistics for hematological variables from clinically normal or healthy Vancouver 
Island Marmots (Marmota vancouverensis) before & after removal of outliers. Used in calculation of reference values 
in accordance with guidelines established by Species 360, formerly the International Species Information System. 
(Teare, 2002) 
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M
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N S.
D
. 
ELECTROLYTES AND 
ACID-BASE 
                                
Sodium   mmol/L 143.7 120.0 164.0 532 4.6 13.9 129.8 157.7 7.0 143.8 130.0 155.8 525 4.0 
Potassium   mmol/L 5.6 3.3 50.0 531 2.8 8.5 -2.9 14.1 9.0 5.4 3.3 13.3 522 1.4 
Sodium / Potassium 
ratio 
  ratio 27.9 3.0 43.6 531 6.5 19.4 8.5 47.3 6.0 28.1 8.6 43.6 525 6.1 
Chloride   mmol/L 102.0 18.0 112.0 529 5.5 16.5 85.5 118.5 1.0 102.1 88.0 112.0 528 4.1 
Bicarbonate   mmol/L 26.4 9.0 39.0 147 5.9 17.6 8.7 44.0 0.0 26.4 9.0 39.0 147 5.9 
Carbon Dioxide   mmol/L 26.4 5.0 38.0 357 5.6 16.8 9.6 43.2 0.0 26.4 5.0 38.0 357 5.6 
Anion Gap     20.9 6.0 75.9 515 7.1 21.4 -0.5 42.3 3.0 20.7 6.0 41.0 512 6.6 
Calcium   mmol/L 2.4 1.4 22.0 601 0.9 2.7 -0.2 5.1 3.0 2.4 1.4 3.3 598 0.2 
Phosphorous   mmol/L 1.9 0.1 5.8 602 0.5 1.6 0.2 3.5 8.0 1.8 0.7 3.5 594 0.5 
Calcium / 
Phosphorous ratio 
  ratio 1.5 0.4 28.3 576 1.3 3.9 -2.5 5.4 3.0 1.4 0.4 4.3 573 0.4 
Calculated Osmolality   mmol/kg 297.5 265.0 355.0 514 7.7 23.1 274.5 320.6 6.0 297.3 276.0 319.0 508 6.7 
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Appendix C. Descriptive statistics for serological variables from clinically normal or healthy Vancouver Island 
Marmots (Marmota vancouverensis) before & after removal of outliers. Used in calculation of reference values in 
accordance with guidelines established by Species 360, formerly the International Species Information System. (Teare, 
2002) 
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N S.
D
. 
PROTEINS                                 
Total Protein   g/L 62.2 6.0 107.0 652 10.2 30.7 31.6 92.9 9.0 62.0 42.0 90.0 643 9.0 
Albumin   g/L 27.8 17.0 84.0 566 5.2 15.6 12.2 43.3 11.0 27.3 17.0 43.0 555 3.6 
Globulin   g/L 33.3 18.6 75.0 561 6.9 20.8 12.4 54.1 8.0 32.9 18.6 53.0 553 6.0 
Albumin / Globulin 
ratio 
A / G 
ratio 
ratio 0.9 0.3 10.0 563 0.5 1.5 -0.6 2.4 2.0 0.9 0.3 1.9 561 0.2 
LIVER AND MUSCLE                                 
Total Bilirubin   μmol/L 2.8 0.0 15.0 435 1.7 5.1 -2.3 7.9 7.0 2.6 0.0 7.0 428 1.4 
Alkaline 
Phosphatase 
ALP IU/L 77.2 5.0 1101.0 564 68.7 206.2 -129.1 283.4 8.0 71.6 5.0 266.0 556 41.3 
Alanine 
Aminotransferase  
ALT IU/L 23.1 1.0 314.0 526 33.4 100.3 -77.1 123.4 14.0 18.6 1.0 117.0 512 17.0 
Aspartate 
Aminotransferase 
AST IU/L 43.9 1.0 601.0 458 61.3 183.9 -139.9 227.8 9.0 37.1 1.0 222.0 449 34.5 
Gamma 
Glutamyltransferase 
GGT IU/L 4.5 0.0 55.0 526 5.1 15.3 -10.8 19.8 10.0 4.0 0.0 18.0 516 3.0 
Creatinine 
Phosphokinase 
CPK IU/L 640.5 56.0 10748.0 595 924.8 2774.5 
-
2134.0 
3414.9 12.0 526.2 56.0 2970.0 583 366.2 
Cholesterol    mmol/L 7.2 3.7 13.1 72 2.0 5.9 1.3 13.2 0.0 7.2 3.7 13.1 72 2.0 
Glucose Gluc mmol/L 8.8 1.2 18.3 637 2.4 7.3 1.5 16.1 7.0 8.8 2.2 15.8 630 2.3 
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Appendix C (cont.) Descriptive statistics for serological variables from clinically normal or healthy Vancouver Island 
Marmots (Marmota vancouverensis) before & after removal of outliers. Used in calculation of reference values in 
accordance with guidelines established by Species 360, formerly the International Species Information System. (Teare, 
2002) 
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N S.
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. 
RENAL FUNCTION                                 
Blood Urea 
Nitrogen 
BUN mmol/L 11.1 3.1 70.0 638 3.8 11.4 -0.3 22.6 6.0 10.9 3.1 22.2 632 2.6 
Creatinine Creat μmol/L 82.5 7.0 224.0 623 23.6 70.7 11.8 153.3 6.0 81.9 18.0 150.0 617 21.8 
Bun / Creatinine 
ratio 
  ratio 0.1 0.0 1.0 623 0.1 0.2 -0.1 0.4 10.0 0.1 0.0 0.4 613 0.1 
OTHER                                 
Lactose 
Dehydrogenase 
LDH IU/L 1785.0 865.0 4068.0 30 822.3 2466.9 
-
681.9 
4251.8 0.0 1785.0 865.0 4068.0 30 822.3 
Amylase   IU/L 878.3 147.0 2373.0 79 481.8 1445.3 
-
567.0 
2323.5 2.0 839.8 147.0 2086.0 77 423.0 
Lipase   IU/L 191.8 60.0 856.0 73 137.2 411.7 
-
219.9 
603.5 0.0 191.8 60.0 856.0 73 137.2 
Tetra 
Iodothyronine 
  nmol/L 57.5 20.0 112.0 152 17.3 52.0 5.5 109.6 1.0 57.2 20.0 91.0 151 16.8 
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Appendix D. Characteristics of very high frequency (VHF) implantable radio-
transmitter used in Vancouver Island Marmots (Marmota vancouverensis) from 
1992 to 2018. 
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Custom 
Telemetry® 
Not recorded 25 90 35 
Not 
recorded 
Pups and 
non-pups 
Wax 
Disinfected 
povidone-
iodine 
solution 
None 
Continuous 
temperature 
response 
1992 
- 
1993 
Telonics® IMP/300/L 23 85 40 1095 Non-pups Wax 
Disinfected 
povidone-
iodine 
solution 
9 
hours 
on      
15 
hours 
off 
Temperature 
triggered 
response                                        
(35 ppm 
above 30°C / 
25 ppm 
below  30°C) 
1994
- 
2009 
Telonics® IMP/325/L 23 100 50 1095 Non-pups Wax 
Disinfected 
povidone-
iodine 
solution 
9 
hours 
on      
15 
hours 
off 
Temperature 
triggered 
response                                        
(35 ppm 
above 30°C / 
25 ppm 
below  30°C) 
2010 
Telonics® IMP/200/L 23 61 25 540 Pups Wax 
Disinfected 
povidone-
iodine 
solution 
9 
hours 
on      
15 
hours 
off 
Temperature 
triggered 
response                                        
(35 ppm 
above 30°C / 
25 ppm 
below  30°C) 
2008
- 
2010 
Advanced 
Telemetry 
Systems® 
M1215T 12 64 13 294 Pups Resin 
Sterilized 
ethylene 
oxide gas 
None 
Continuous 
temperature 
response 
2011 
- 
2013 
Advanced 
Telemetry 
Systems® 
M1230T 18 68 25 728 Pups Resin 
Sterilized 
ethylene 
oxide gas 
None 
Continuous 
temperature 
response 
2011 
- 
2013 
Advanced 
Telemetry 
Systems® 
M1240T 20 78 40 1226 Non-pups Resin 
Sterilized 
ethylene 
oxide gas 
None 
Continuous 
temperature 
response 
2011 
- 
2013 
Holohil 
Systems® 
A1-2TH 19 79 35 1095 Non-pups 
Plasti 
Dip®      
(butyl 
rubber) 
Disinfected 
povidone-
iodine 
solution 
None 
Continuous 
temperature 
response 
2006 
- 
2009 
Holohil 
Systems® 
A1-2TH 25 90 55 1800 Non-pups 
Plasti 
Dip®      
(butyl 
rubber) 
Sterilized 
ethylene 
oxide gas 
None 
Continuous 
temperature 
response 
2009 
- 
2011 
Holohil 
Systems® 
A1-2TH 25 90 50 1800 Non-pups Resin 
Sterilized 
ethylene 
oxide gas 
None 
Continuous 
temperature 
response 
2012 
- 
2018 
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Appendix D. (cont.) Characteristics of very high frequency (VHF) implantable 
radio-transmitter used in Vancouver Island Marmots (Marmota vancouverensis) 
from 1992 to 2018. 
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Holohil 
Systems® 
S1-2TH 15 65 18 540 Pups 
Plasti 
Dip®      
(butyl 
rubber) 
Sterilized 
ethylene 
oxide gas 
None 
Continuous 
temperature 
response 
2007 
- 
2011 
Holohil 
Systems® 
S1-2TH 15 65 18 540 Pups Resin 
Sterilized 
ethylene 
oxide gas 
None 
Continuous 
temperature 
response 
2012 
- 
2013 
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Appendix E. Summary of Vancouver Island Marmot (Marmota vancouverensis) 
implant surgeries, 1992 to 2018. 
 
 Wild marmots Captive-release marmots  
Year 
new 
surgeries 
replacement 
surgeries 
total (wild & 
translocation) 
wild 
population 
estimate 
% of total 
wild 
population 
new 
surgeries 
(pre-
release) 
replacement 
surgeries        
(post release) 
Annual 
Total 
1992 7 0 7 211 3.3 0 0 7 
1993 11 2 13 189 6.9 0 0 13 
1994 6 3 9 233 3.9 0 0 9 
1995 4 0 4 139 2.9 0 0 4 
1996 4 0 4 122 3.3 0 0 4 
1997 2 0 2 118 1.7 0 0 2 
1998 4 0 4 74 5.4 0 0 4 
1999 3 0 3 60 5.0 0 0 3 
2000 7 0 7 51 13.7 0 0 7 
2001 12 2 14 43 32.6 0 0 14 
2002 7 1 8 41 19.5 1 0 9 
2003 3 6 9 31 29.0 3 0 13 
2004 1 6 7 32 21.9 9 0 17 
2005 8 3 11 40 27.5 15 0 26 
2006 3 0 3 60 5.0 30 2 35 
2007 9 0 9 68 13.2 37 1 47 
2008 3 4 7 100 7.0 59 2 68 
2009 18 3 21 160 13.1 68 4 93 
2010 30 3 33 280 11.8 85 5 123 
2011 12 1 13 350 3.7 67 6 86 
2012 19 11 30 375 8.0 32 11 73 
2013 57 8 65 313 20.8 16 0 81 
2014 35 2 37 245 15.1 27 0 64 
2015 26 3 29 240 12.1 24 1 54 
2016 23 7 30 166 18.1 13 1 44 
2017 13 4 17 150 11.3 11 33 28 
2018 24 5 29 145 20.0 14 0 43 
Total 353 72 425 
149 
(average) 
12.4 
(average) 
511 33 969 
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Appendix F. Trapping, handling, anesthesia & implant surgery techniques in 
Vancouver Island Marmots (Marmota vancouverensis) 
 
Trapping  
Free-ranging marmots were captured using live-traps (Havahart® model # 
1079, dimensions 32” x 10” x 12”) which were baited with a trail of peanut butter or 
set up so that they represented the marmot’s only option for egress from a burrow. 
Traps set for marmots were continuously monitored or checked frequently. Because 
of their susceptibility to hyperthermia (Ken Langelier, personal communication, 
1992), marmots were not typically handled or immobilized if ambient temperatures 
exceeded 20C. Following capture, marmots held in live traps were covered with a 
fitted trap-cover to provide shade, minimize stress, and to act as a visual barrier to 
reduce self-trauma associated with hitting the sides of the wire trap. Marmots 
undergoing implantation were transported to a central field site for surgery. The 
distance to this site was minimized so that transport was as quick and efficient as 
logistically possible. Hunter pack-frames were often used to carry the trapped 
marmot to the handling location. In hot weather, a sealed plastic bag containing 
flattened snow (if available) or an ice-pack were placed beneath a portion of the trap 
on the pack-frame’s shelf to facilitate cooling during transport. Marmots trapped at 
Mount Washington were often transported by foot or by vehicle to the Tony Barrett 
Mount Washing Marmot Recovery Centre (MRC) for implant surgery or for 
examination and staging prior to translocation. Wild marmots captured for the 
captive breeding program were trapped, examined, and then directly transported to 
the Toronto Zoo (total = 26), Calgary Zoo (25) by vehicle and commercial airline, or 
to the MRC (10) by vehicle.    
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Handling 
For most procedures involving sampling, marking or examination of captive 
or free-ranging marmots, chemical restraint was required. Excessive physical 
restraint of the marmots was avoided because of the potential for traumatic injuries 
including diaphragmatic hernias which have occurred in woodchucks at Cornell 
University following physical restraint, (Tennant, personal communication, 2001) 
and hyperthermia. The marmots were run into a tapered, cloth handling bag which 
fit snugly around the end of the trap or against the doorway of their nest-box. Any 
obstacle such as rocks or branches lying in the “run-way” area of the cloth bag was 
removed beforehand to avoid injury to the marmot. In captivity, the concrete floor 
was padded by pulling additional shavings into the “run-way” area. Once the 
marmot had reached the apex of the bag, the bag was gripped or twisted behind the 
animal to provide better restraint and prevent its turning or egress, taking care to 
not grab its tail.   
Immobilization / Anesthesia 
Once they were manually restrained in the handling bag the marmots 
received an intramuscular injection of ketamine hydrochloride (10 mg/kg) and 
midazolam hydrochloride (0.25 mg/kg). Ketamine hydrochloride (100 mg/ml) was 
combined with midazolam hydrochloride (5 mg/ml) in a 2:1 ratio and administered 
at an approximate volume of 0.15 ml / kg into the epaxial or lumbar muscles, which 
were palpated and isolated through the wall of the bag. Following injection, care 
was taken so that the marmot was not excessively wrapped or physically restrained 
within the bag, which could increase its struggling, elevate its body temperature, or 
interfere with its breathing. Marmots were monitored for a suitable drug response 
through the wall of the bag. This included reduced struggling, progressive muscle 
relaxation, loss of balance or a righting response, reduced response to tactile stimuli 
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and slower, deeper respirations. They were held in the bag until they were 
sufficiently tractable or immobilized for safe handling. Typically, younger marmots 
(pups and yearlings) were found to be less responsive to the dosage regime than 
adults. The drugs also appeared to have a more profound effect on the marmots 
later in the active season (i.e. more pronounced in September and October).       
Once the marmot was sufficiently tractable, it was removed from the 
handling bag and further induced with inhaled isoflurane. The marmots were given 
a titrated gas mixture consisting of oxygen (delivered at approximately 1 liter per 
minute from a “click” style oxygen flow-meter / regulator) fed through a calibrated, 
Tech 3 isoflurane vaporizer, typically set at an initial level between 2.5 and 3.5%. The 
gas mixture was delivered to the animal through a modified Jackson Rees non-
rebreathing circuit mated to a clear plastic anesthesia mask. The anesthesia mask 
was fitted with a flexible diaphragm (made from a fenestrated surgical glove taped 
to its rim) which formed an effective seal around the marmot’s head to minimize gas 
leakage. Due to the short duration of most procedures, the difficulty of visualizing 
the glottis and epiglottis, the potential for oropharyngeal trauma, and marmot 
anatomical characteristics (obligate nasal breathers and limited capacity for 
regurgitation and gastric reflux) marmots were not routinely intubated during 
anesthesia. In some instances, pups were manually restrained in the handling bag 
and mask induced without receiving any injectable immobilization agents. 
Respiratory rate, heart rate and body temperature were continuously 
monitored during immobilizations and anaesthesia. Respirations were monitored 
visually and with a pulse oximeter. Heart rate was monitored using a stethoscope, a 
pulse oximeter providing pulse rate data and / or a Doppler heart rate monitor with 
the probe positioned over the medial aspect of the distal tibia (just proximal to the 
tarsus). Body temperature were monitored using a digital rectal thermometer. In 
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some instances, particularly early in the active season when fat reserves are low, 
marmots were provided with a source of supplemental heat such as latex gloves 
filled with warmed water or an insulated heating pad. To effect cooling on warm 
days a sealed plastic bag containing flattened snow (if available) or an ice-pack were 
placed in the areas of greatest heat exchange (inner thigh, abdomen, shoulders, 
axilla) or the extremities were wetted with isopropyl alcohol.  
Implant surgery 
As much as possible, surgically implanted, intra-abdominal transmitters were 
used to monitor free-ranging marmots. Internal transmitters were used because the 
dramatic seasonal mass changes that are associated with marmot hibernation made 
conventional collars impractical. Implant surgeries were routinely performed in the 
dedicated surgery at the TBMWMRC or in the field using high standards of 
anesthesia and aseptic technique. Because implantation required a surgical 
procedure and an adequate capacity for convalescence, marmots were not implanted 
close to hibernation (i.e. early in the field season following emergence when body 
condition and food resources were low and when female marmots might be 
pregnant, or late in the field season close to immergence when the marmots’ 
metabolic rate was starting to decline and healing capacity might be reduced). Most 
surgeries were performed between the middle of June and the end of August. 
During the course of this project, temperature-responsive transmitters from Custom 
Telemetry ® (Watkinsville, Georgia), Telonics ® (Mesa, Arizona), Advanced 
Telemetry Systems ® (Isanti, Minnesota) and Holohil Systems Limited ® (Carp, 
Ontario) were used. The pulse rate and temperature response of the transmitters 
was configured to maximize functionality and prolong battery life. Pulse rate 
declines associated with lowered body temperature helped to prolong battery life 
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during hibernation and during the active season a low transmitter pulse rate was 
used to indicate potential marmot mortalities.  
From 1992 to 2016 a total of 898 implant surgeries were performed on 
Vancouver Island marmots including 96 replacement surgeries. Most of the captive 
marmots being prepared for release were surgically implanted with radio-
transmitters and then afforded a period of convalescence in captivity. Intervals 
between captive surgery and release ranged from 11 to 93 days (mean = 28 days). 
Three marmots were held until the following year due to transient injuries that 
precluded same-year release and one individual died due to pre-release 
complications with its transmitter. 484 of the 490 captive-release marmots were 
surgically implanted with an abdominal radio transmitter prior to release and 32 of 
these individuals were later recaptured and had their transmitters replaced. One 
individual was recaptured a second time for transmitter replacement and one 
individual was recaptured and surgically implanted 50 days after being initially 
released without a transmitter.  
From 1992 to 2016 a total of 379 implant surgeries were performed on wild 
marmots (including marmots that were subsequently translocated), including 63 
replacement surgeries. Wild marmots being intentionally prepared for translocation 
were surgically implanted with radio-transmitters and then allowed to convalesce at 
their familiar colony sites. Although 14 days was deemed to be the minimal interval 
between field surgery and translocation, this period actually ranged from 21 to 37 
days (mean = 30 days) due to challenges associated with recapture, weather, and 
other field logistics. In five instances, wild marmots were not recaptured and 
translocated until the following year following surgery. Four marmots which were 
captured at aberrant locations including Bamfield, Nanaimo and Nanoose on 
Vancouver Island were surgically implanted and translocated to suitable habitat 
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within days of capture. All four marmots survived for at least 350 days (range 350 to 
1511 days), indicating that these marmots were not adversely affected by prompt 
relocation following surgery.         
All marmots received a comprehensive physical examination prior to 
surgery. Individuals that were inappropriately sized, compromised by injury, or 
exhibiting evidence of disease were not implanted with transmitters.    
Surgical technique 
Following physical examination and placement of the monitoring equipment, 
marmots were positioned in a v-trough in dorsal recumbency. The fur from a small 
area of approximately 7 cm long × 5 cm wide was clipped from the ventral 
abdominal midline. The surgical site was cleaned and disinfected using a routine 
surgical preparation, consisting of a series of at least three chlorhexidine (or 
povidone iodine scrub) washes / isopropyl rinses, and finishing with a final 
application of a povidone iodine solution. To minimize effects on post-surgical 
thermoregulation, excessive removal or wetting of the fur was avoided. All surgeries 
were performed using sterile surgical gloves, surgical masks / caps, autoclaved, 
sterile surgical instruments, sterile occlusive drapes, and aseptic technique. A 
nonporous, transparent, self-adhesive fenestration drape (Veterinary Specialty 
Products, Overland Park, KS) was positioned over the surgical site. A longitudinal 
skin incision approximately 3 cm in length is made along the ventral midline to 
expose the linea alba, which was then incised after elevation of the body wall. Care 
was taken so that the underlying, voluminous, thin-walled intestines were not 
perforated during the initial incision. The incision into the abdominal cavity was 
extended as necessary using sharp dissection. At an appropriate point the 
transmitter was removed from its sterile packaging or disinfectant solution. If it had 
been in a disinfectant solution the unit was well rinsed with warm sterile saline or 
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lactated Ringer’s solution. The functioning and frequency of the transmitter was 
reconfirmed prior to placement. The transmitter was inserted into the abdominal 
cavity and positioned laterally and longitudinally, away from the incision site. 
Bleeding during the procedure was minimal. 3-0 PDS II (polydioxanone) an 
absorbable, synthetic, monofilament suture (Ethicon, Inc., Somerville, NJ) was used 
for closure of all tissue layers. Simple, interrupted sutures were used to close the 
body wall. A simple, continuous pattern was used to close the subcutaneous fat and 
a subcuticular suture was used to close the skin. Additional simple interrupted skin 
sutures and a thin layer of surgical tissue adhesive (Vetbond, 3M, St Paul, MN), 
were also be used to provide additional security of the skin incision. Beginning in 
2013, injectable analgesics (Subcutaneous injection of 0.1 to 0.2 mg/kg of Meloxicam, 
Metacam, Boehringer Ingelheim Vetmedica, Ridgefield, CT) were administered 
preoperatively. Antibiotics were not routinely administered but were given on 
occasion at the discretion of the surgeon.  
Recovery 
Following surgery, measurements and sample collection, the isoflurane was 
discontinued, and the marmot was given a short interval of pure oxygen. Increased 
muscle tone and spontaneous postural changes (head up, rising to sternal 
recumbency) were typically observed within minutes of discontinuing isoflurane. 
After these initial signs were observed, the marmot was returned to its trap and 
monitored for further recovery. Once the marmot had attained normal posture and 
demeanour its trap was covered and placed in a quiet, thermally “neutral” area (not 
too hot or too cold and out of direct sunlight) and checked periodically. Induction to 
recovery times were approximately 45 minutes, depending upon additional 
manipulations (measurements, diagnostics, sampling, etc.) that were being 
performed. Marmots were held for a minimum of 45 to 60 minutes following 
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discontinuation of the isoflurane before being returned to their nest-box or into a 
familiar burrow close to their original capture site. Marmots were not transported 
until they could effectively maintain their balance within the trap (verified by slight 
tipping of the trap) in order to reduce the risk of trauma associated with losing their 
balance while being carried over rough terrain. Mild and transient post-operative 
imbalance was attributed to the residual effects of ketamine. The duration of the 
midazolam’s sedative effects lasted 60 to 90 minutes (exceeding ketamine’s duration 
of action which is approximately 30 to 45 minutes) and wild marmots typically 
remained calm during recovery and subsequent transport back to the release site.  
Potential complications associated with implantation were mitigated by 
minimizing animal stress and handling time, employing sound surgical techniques, 
and by careful selection and handling of the implant units. From 1992 to 2010, 
transmitters were disinfected by soaking in a povidone-iodine solution for a 
minimum of 12 hours. These units were subsequently rinsed with Lactated Ringers 
Solution or physiological saline prior to placement. Beginning in 2011, all 
transmitters were gas sterilized with ethylene oxide. Transmitters with surface 
defects were avoided, particularly in the case of “soft” encapsulation materials such 
as Plasti-dip® and wax. Observations during early replacement surgeries indicated 
that surface irregularities may have led to the development of focal adhesions 
between the transmitter and the greater omentum. To date, two fatal complications 
arising directly from an implanted transmitter have been documented. In one case, 
extreme post-emergence weight loss in a structurally large, captive-release adult 
male resulted in the transmitter becoming lodged in its pelvic canal, resulting in a 
fatal impaction of the gastrointestinal tract. In the second case, involving a captive 
marmot scheduled for release, the outer surface of the transmitter caused an 
extreme, chronic inflammatory reaction with significant visceral adhesions which 
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could not be surgically resolved. These problems were subsequently mitigated by 
having the manufacturer increase the diameter of the transmitters and by only using 
transmitters encapsulated in a hard, biologically inert resin.  
 
               
Lateral (left) and ventrodorsal radiographs of free-floating abdominal radio-transmitter in female 
Vancouver Island Marmot (Marmota vancouverensis). The cylindrical unit was 25 mm x 90 mm 
and weighed 50 grams.    
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Appendix G. Summary of morbidity & mortality in captive & free-ranging 
Vancouver Island Marmots (Marmota vancouverensis), 1992 to 2016 
 
System Diagnosis 
Identified or 
diagnosed by 
clinical signs or 
physical 
examination 
Diagnosis 
requires 
necropsy or 
ancillary lab 
test(s) 
Identified in 
free-ranging 
marmots 
Identified in 
captive 
marmots 
abdominal abdominal abscess N Y N Y 
abdominal peritonitis N Y N Y 
abdominal colonic impaction due to transmitter N Y Y N 
abdominal transmitter reaction Y confirmed N Y 
cardiovascular atrial septal defect Y confirmed N Y 
cardiovascular persistent tachycardia Y confirmed N Y 
cardiovascular patent foramen ovale Y confirmed N Y 
cardiovascular cardiomyopathy Y confirmed N Y 
cardiovascular endocardiosis Y confirmed N Y 
cardiovascular cerebral hemorrhage N Y N Y 
cardiovascular atherlosclerosis N Y N Y 
dental dental malocclusions Y N N Y 
dental 
unilateral / bilateral fractures of upper 
incisors 
Y N Y Y 
gastrointestinal segmented enteritis, N Y N Y 
gastrointestinal roundworms Y/N Y Y Y 
gastrointestinal tapeworms Y/N Y Y Y 
gastrointestinal mesenteric torsion N Y N Y 
gastrointestinal duodenal ulcer and peritonitis N Y N Y 
gastrointestinal pancreatitis with peritonitis N Y N Y 
gastrointestinal perforated ceacal ulcer with peritonitis N Y N Y 
hepatic cholangiohepatitis N Y N Y 
hepatic hepatitis N Y N Y 
integumentary fleas Y N Y Y 
integumentary ticks Y N Y N 
integumentary facial abscess Y N Y Y 
integumentary mites Y confirmed Y Y 
integumentary cutaneous bots Y N N Y 
multisystemic stunting, post weaning un-thriftiness Y N Y Y 
multisystemic septicemia N Y N Y 
multisystemic capture-related hyperthermia, Y N Y N 
multisystemic facial neoplasia Y confirmed N Y 
multisystemic perivasculitis N Y N Y 
multisystemic malignant histiocytosis N Y N Y 
multisystemic conspecific trauma Y confirmed Y Y 
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Appendix G. (cont.) Summary of morbidity & mortality in captive & free-ranging 
Vancouver Island Marmots (Marmota vancouverensis), 1992 to 2016. 
 
System Diagnosis 
Identified or 
diagnosed by 
clinical signs or 
physical 
examination 
Diagnosis 
requires 
necropsy or 
ancillary lab 
test(s) 
Identified in 
free-ranging 
marmots 
Identified in 
captive 
marmots 
multisystemic neoplasia Y / N confirmed N Y 
musculoskeletal spondylosis N Y N Y 
musculoskeletal scoliosis Y confirmed N Y 
musculoskeletal hind foot aplasia Y N N Y 
musculoskeletal toe injuries from conspecific trauma Y N Y Y 
musculoskeletal chronic fracture of right olecranon Y confirmed N Y 
musculoskeletal fracture of carpal bones Y confirmed Y N 
musculoskeletal post hibernation emaciation Y confirmed Y Y 
musculoskeletal abdominal hernia Y confirmed N Y 
musculoskeletal resorption of head and neck of femur N Y N Y 
musculoskeletal 
degeneration and herniation of 
intervertebral disc(s) 
Y confirmed N Y 
neurologic head trauma Y confirmed N Y 
neurological menigoencephalomyelitis Y confirmed N Y 
ocular unilateral anopthalmis Y N N Y 
ocular bilateral, congenital cataracts Y confirmed N Y 
ocular corneal trauma with opacity Y confirmed Y Y 
ocular lenticular opacity Y N N Y 
ocular unilateral, corneal opacity Y N N Y 
ocular narrowed palpebral fissure Y N N Y 
respiratory bronchopneumonia Y/N confirmed N Y 
respiratory pulmonary adenomatosis N Y N Y 
respiratory laryngeal occlusion N Y N Y 
urogenital vaginitis, urethritis and cystitis N Y N Y 
urogenital paraphimosis Y N N Y 
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Appendix H. Summary of annual mortality categories in free-ranging Vancouver Island Marmots (Marmota 
vancouverensis) 1992 to 2016.  
Year 
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Wild 1 0 2 1 0 0 3 0 0 2 6 1 4 1 3 1 0 2 10 7 8 18 30 26 13 139 
Predation 0 0 2 1 0 0 3 0 0 2 5 1 3 0 2 0 0 2 6 5 1 13 16 4 7 73 
Hibernation 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 0 0 2 1 1 4 2 8 
Other 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 3 
Unknown 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 4 2 5 4 13 17 4 55 
Translocated 0 0 0 0 5 0 0 0 0 0 1 2 0 0 0 0 0 1 1 0 1 2 4 10 20 44 
Predation 0 0 0 0 1 0 0 0 0 0 1 2 0 0 0 0 0 1 0 0 0 0 0 0 0 5 
Hibernation 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 5 
Other 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Unknown 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 2 3 10 20 34 
Captive-
release 
0 0 0 0 0 0 0 0 0 0 0 3 1 9 10 14 26 28 62 47 47 28 16 26 14 330 
Predation 0 0 0 0 0 0 0 0 0 0 0 3 1 4 7 9 12 11 13 6 6 4 4 6 2 87 
Hibernation 0 0 0 0 0 0 0 0 0 0 0 0 0 4 3 2 7 7 27 7 11 3 5 1 3 80 
Other 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 0 1 1 0 0 5 
Unknown 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 7 9 22 34 30 20 6 19 9 158 
Pre-
conditioned 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 3 10 4 20 
Predation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 2 
Hibernation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 2 0 5 
Other 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Unknown 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 8 4 13 
Total  
mortalities 
1 0 2 1 5 0 3 0 0 2 7 6 5 10 13 15 26 31 73 54 57 49 53 72 48 533 
 
1
38
 
139 
 
 
Appendix I. A comparison of common body condition indices in wild & captive male Vancouver Island Marmots 
(Marmota vancouverensis). Unpublished data.  
 
 
 
Body mass 
divided by 
body length           
(BM/BL) 
Quetlet's Index                             
Body mass 
divided by 
body length 
squared     
(B/L²) 
Fulton's 
Index                                
Body mass 
divided by 
body length 
cubed                              
(B/L³) 
Log-
transformed 
body mass 
divided by log-
transformed 
body length                                  
(log BM/log BL) 
Scaled mass 
index (gm)       
(a) 
Scaled neck 
index (cm)       
(b) 
Captive males 89.75397 1.740848 0.03404794 2.137128 4110.01 26.63 
Wild males 74.59246 1.520057 0.03149986 2.101056 3816.77 24.05 
t 10.384 9.7093 5.761 9.4526 5.42 14.64 
df 366.411 382.125 419.318 348.421 420.23 413.15 
PV < 2.2e-16 < 2.2e-16 1.62E-08 < 2.2e-16 9.90E-08 < 2.2e-16 
 
(a) Scaled mass index (sci) comparing body mass of captive and wild marmots according to a standardized body length of 
49.45 cm (mean body length for all samples).    
(b) Scaled neck index - comparing neck circumference of captive and wild marmots according to a standardized body 
length of 49.45 cm (mean body length for all samples).              
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